Publications from OUS - Dept. of Microbiology, Kaarbø - Virology research group

389 publications found

Publications 2024

1. Onken A, Moyo S, Miraji MK, Bohlin J, Marijani M, Manyahi J, Kibwana KO, Müller F, Jenum PA, Abeid KA, Reimers M, Langeland N, Mørch K, Blomberg B (2024)
   Predominance of multidrug-resistant Salmonella Typhi genotype 4.3.1 with low-level ciprofloxacin resistance in Zanzibar
   PLoS Negl Trop Dis, 18 (4), e0012132 (in press)
   DOI 10.1371/journal.pntd.0012132, PubMed 38630840
2. Ørbo HS, Bjørlykke KH, Sexton J, Jyssum I, Tveter AT, Christensen IE, Mjaaland S, Kvien TK, Grødeland G, Kro GB, Jahnsen J, Haavardsholm EA, Munthe LA, Provan SA, Vaage JT, Goll GL, Jørgensen KK, Syversen SW (2024)
   Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
   RMD Open, 10 (2)
   DOI 10.1136/rmdopen-2023-003545, PubMed 38599653

Publications 2023

1. Blom KB, Birkeland GK, Midtvedt K, Jenssen TG, Reisæter AV, Rollag H, Hartmann A, Sagedal S, Sjaastad I, Tylden G, Njølstad G, Nilsen E, Christensen A, Åsberg A, Birkeland JA (2023)
   Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
   Transplantation, 107 (8), 1846-1853
   DOI 10.1097/TP.0000000000004615, PubMed 37211633
2. Brendefur Corwin LM, Campbell P, Jakobsen K, Müller F, Lai X, Unemo M, Leegaard TM, Vildershøj Bjørnholt J, Olsen AO (2023)
   Improvement in Neisseria gonorrhoeae culture rates by bedside inoculation and incubation at a clinic for sexually transmitted infections
   Ann Clin Microbiol Antimicrob, 22 (1), 27
   DOI 10.1186/s12941-023-00576-0, PubMed 37072830
3. Corwin LMB, Ingebretsen A, Campbell P, Alfsnes K, Müller F, Mauder N, Koomey M, Bjørnholt JV (2023)
   Fourier transform infrared spectroscopy; can it be used as a rapid typing method of Neisseria gonorrhoeae?
   J Microbiol Methods, 205, 106675
   DOI 10.1016/j.mimet.2023.106675, PubMed 36681126
4. Garcia I, Lee Y, Brynildsrud O, Eldholm V, Magnus P, Blomfeldt A, Leegaard TM, Müller F, Dudman S, Caugant DA (2023)
   Tracing the adaptive evolution of SARS-CoV-2 during vaccine roll-out in Norway
   Virus Evol, 10 (1), vead081
   DOI 10.1093/ve/vead081, PubMed 38205440
5. Jiang X, Liu S, Fu YR, Liu XJ, Li XJ, Yang B, Jiang HF, Shen ZZ, Alemu EA, Vazquez P, Tang Y, Kaarbø M, McVoy MA, Rayner S, Luo MH (2023)
   Human cytomegalovirus infection perturbs neural progenitor cell fate via the expression of viral microRNAs
   J Med Virol, 95 (2), e28574
   DOI 10.1002/jmv.28574, PubMed 36772841
6. Kared H, Alirezaylavasani A, Lund KP, Chopra A, Tietze L, de Matos Kasahara T, Goll GL, Grødeland G, Kaarbø M, Reisæter AV, Hovd M, Heldal K, Vaage JT, Lund-Johansen F, Midtvedt K, Åsberg A, Munthe LA (2023)
   Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
   EBioMedicine, 97, 104833
   DOI 10.1016/j.ebiom.2023.104833, PubMed 37844534
7. Ravlo E, Ianevski A, Starheim E, Wang W, Ji P, Lysvand H, Smura T, Kivi G, Voolaid ML, Plaan K, Ustav M, Ustav M, Zusinaite E, Tenson T, Kurg R, Oksenych V, Walstad K, Nordbø SA, Kaarbø M, Ernits K, Bjørås M, Kainov DE, Fenstad MH (2023)
   Boosted production of antibodies that neutralized different SARS-CoV-2 variants in a COVID-19 convalescent following messenger RNA vaccination - a case study
   Int J Infect Dis, 137, 75-78
   DOI 10.1016/j.ijid.2023.10.011, PubMed 37852599
8. Ravlo E, Sousa MML, Andersen LL, Holberg-Petersen M, Klundby I, Aas PA, Hagen L, Erlandsen SE, Malmring JF, Ali Z, Sharma A, Ottesen V, Bandyopadhyay S, Bjørås M (2023)
   A fast, low-cost, robust and high-throughput method for viral nucleic acid isolation based on NAxtra magnetic nanoparticles
   Sci Rep, 13 (1), 11714
   DOI 10.1038/s41598-023-38743-0, PubMed 37474666
9. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
   Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
   NPJ Vaccines, 8 (1), 4
   DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Publications 2022

1. Bjørlykke KH, Ørbo HS, Tveter AT, Jyssum I, Sexton J, Tran TT, Christensen IE, Kro GB, Kvien TK, Jahnsen J, Munthe LA, Chopra A, Warren DJ, Mjaaland S, Haavardsholm EA, Grødeland G, Provan SA, Vaage JT, Syversen SW, Goll GL, Jørgensen KK (2022)
   Four SARS-CoV-2 vaccine doses or hybrid immunity in patients on immunosuppressive therapies: a Norwegian cohort study
   Lancet Rheumatol, 5 (1), e36-e46
   DOI 10.1016/S2665-9913(22)00330-7, PubMed 36415604
2. Blom K, Jørstad ØK, Faber RT, Stene-Johansen I, Holberg-Petersen M, Hermansen NO, Bragadóttir R (2022)
   Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study
   Acta Ophthalmol, 101 (1), 100-108
   DOI 10.1111/aos.15207, PubMed 35751448
3. Christensen IE, Jyssum I, Tveter AT, Sexton J, Tran TT, Mjaaland S, Kro GB, Kvien TK, Warren DJ, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Grødeland G, Lund-Johansen F, Jørgensen KK, Syversen SW, Goll GL, Provan SA (2022)
   The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study
   BMC Med, 20 (1), 378
   DOI 10.1186/s12916-022-02587-8, PubMed 36199139
4. Degenhardt F, Ellinghaus D, Juzenas S, Lerga-Jaso J, Wendorff M, Maya-Miles D, Uellendahl-Werth F, ElAbd H, Rühlemann MC, Arora J, Özer O, Lenning OB, Myhre R, Vadla MS, Wacker EM, Wienbrandt L, Blandino Ortiz A, de Salazar A, Garrido Chercoles A, Palom A, Ruiz A, Garcia-Fernandez AE, Blanco-Grau A, Mantovani A, Zanella A et al. (2022)
   Detailed stratified GWAS analysis for severe COVID-19 in four European populations
   Hum Mol Genet, 31 (23), 3945-3966
   DOI 10.1093/hmg/ddac158, PubMed 35848942
5. Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC (2022)
   Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
   Viruses, 14 (11)
   DOI 10.3390/v14112420, PubMed 36366518
6. Gregersen I, Ueland T, Holter JC, Olsen MB, Michelsen AE, Murphy SL, Tveita AA, Henriksen KN, Hoel H, Nordberg LB, Holten AR, Edvardsen T, Yang K, Heggelund L, Trøseid M, Müller F, Kildal AB, Dyrhol-Riise AM, Barratt-Due A, Dahl TB, Aukrust P, Halvorsen B, NOR-SOLIDARITY consortium, The Norwegian SARS-CoV-2 Study Group investigators (2022)
   CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19
   J Infect, 85 (6), 702-769
   DOI 10.1016/j.jinf.2022.09.029, PubMed 36216188
7. Kaarbø M, Yang M, Hov JR, Holm K, de Sousa MML, Macpherson ME, Reims HM, Kran AB, Halvorsen B, Karlsen TH, Aukrust P, Lundin KEA, Fevang B, Bjørås M, Jørgensen SF (2022)
   Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses
   J Allergy Clin Immunol, 151 (3), 767-777
   DOI 10.1016/j.jaci.2022.09.029, PubMed 36220400
8. Onken A, Haanshuus CG, Miraji MK, Marijani M, Kibwana KO, Abeid KA, Mørch K, Reimers M, Langeland N, Müller F, Jenum PA, Blomberg B (2022)
   Malaria prevalence and performance of diagnostic tests among patients hospitalized with acute undifferentiated fever in Zanzibar
   Malar J, 21 (1), 54
   DOI 10.1186/s12936-022-04067-z, PubMed 35183188
9. Ravlo E, Evensen L, Sanson G, Hildonen S, Ianevski A, Skjervold PO, Ji P, Wang W, Kaarbø M, Kaynova GD, Kainov DE, Bjørås M (2022)
   Antiviral Immunoglobulins of Chicken Egg Yolk for Potential Prevention of SARS-CoV-2 Infection
   Viruses, 14 (10)
   DOI 10.3390/v14102121, PubMed 36298676
10. Syversen SW, Jyssum I, Tveter AT, Sexton J, Christensen IE, Tran TT, Bjørlykke KH, Mjaaland S, Warren DJ, Kvien TK, Chopra A, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Grødeland G, Vaage JT, Provan SA, Jørgensen KK, Goll GL (2022)
    Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
    RMD Open, 8 (2)
    DOI 10.1136/rmdopen-2022-002417, PubMed 36328399
11. Syversen SW, Jyssum I, Tveter AT, Tran TT, Sexton J, Provan SA, Mjaaland S, Warren DJ, Kvien TK, Grødeland G, Nissen-Meyer LSH, Ricanek P, Chopra A, Andersson AM, Kro GB, Jahnsen J, Munthe LA, Haavardsholm EA, Vaage JT, Lund-Johansen F, Jørgensen KK, Goll GL (2022)
    Immunogenicity and Safety of Standard and Third-Dose SARS-CoV-2 Vaccination in Patients Receiving Immunosuppressive Therapy
    Arthritis Rheumatol, 74 (8), 1321-1332
    DOI 10.1002/art.42153, PubMed 35507355
12. Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
    Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
    Front Immunol, 13, 964525
    DOI 10.3389/fimmu.2022.964525, PubMed 36159859
13. Søvik S, Barrat-Due A, Kåsine T, Olasveengen T, Strand MW, Tveita AA, Berdal JE, Lehre MA, Lorentsen T, Heggelund L, Stenstad T, Ringstad J, Müller F, Aukrust P, Holter JC, Nordøy I (2022)
    Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation
    J Infect, 85 (1), 57-63
    DOI 10.1016/j.jinf.2022.05.015, PubMed 35605805
14. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
    Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
    NPJ Vaccines, 7 (1), 174
    DOI 10.1038/s41541-022-00586-7, PubMed 36585405
15. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
    Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
    J Intern Med, 292 (5), 816-828
    DOI 10.1111/joim.13549, PubMed 35982589
16. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
    High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
    J Infect Dis, 226 (12), 2150-2160
    DOI 10.1093/infdis/jiac313, PubMed 35876699

Publications 2021

1. Barratt-Due A, Olsen IC, Nezvalova-Henriksen K, Kåsine T, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Kildal AB, Berg Å, Johannessen A, Heggelund L, Dahl TB, Skåra KH, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR, Olsen RB et al. (2021)
   Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial
   Ann Intern Med, 174 (9), 1261-1269
   DOI 10.7326/M21-0653, PubMed 34251903
2. Jyssum I, Kared H, Tran TT, Tveter AT, Provan SA, Sexton J, Jørgensen KK, Jahnsen J, Kro GB, Warren DJ, Vaage EB, Kvien TK, Nissen-Meyer LH, Anderson AM, Grødeland G, Haavardsholm EA, Vaage JT, Mjaaland S, Syversen SW, Lund-Johansen F, Munthe LA, Goll GL (2021)
   Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study
   Lancet Rheumatol, 4 (3), e177-e187
   DOI 10.1016/S2665-9913(21)00394-5, PubMed 34977602
3. Kåsine T, Dyrhol-Riise AM, Barratt-Due A, Kildal AB, Olsen IC, Nezvalova-Henriksen K, Lund-Johansen F, Hoel H, Holten AR, Tveita A, Mathiessen A, Haugli M, Eiken R, Berg Å, Johannessen A, Heggelund L, Dahl TB, Halvorsen B, Mielnik P, Le LAK, Thoresen L, Ernst G, Hoff DAL, Skudal H, Kittang BR et al. (2021)
   Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial
   J Intern Med, 291 (2), 241-243
   DOI 10.1111/joim.13377, PubMed 34411368
4. Landaas ET, Taxt AM, Lind A, Müller F (2021)
   [The COVID-19 pandemic – experiences from a microbiology laboratory]
   Tidsskr Nor Laegeforen, 141 (18)
   DOI 10.4045/tidsskr.21.0643, PubMed 34911278
5. Lerum TV, Maltzahn NN, Aukrust P, Trøseid M, Henriksen KN, Kåsine T, Dyrhol-Riise AM, Stiksrud B, Haugli M, Blomberg B, Kittang BR, Johannessen A, Hannula R, Aballi S, Kildal AB, Eiken R, Dahl TB, Lund-Johansen F, Müller F, Rodriguez JR, Meltzer C, Einvik G, Ueland T, Olsen IC, NOR-SOLIDARITY Consortium et al. (2021)
   Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9
   Sci Rep, 11 (1), 23205
   DOI 10.1038/s41598-021-02547-x, PubMed 34853380
6. Lind A, Barlinn R, Landaas ET, Andresen LL, Jakobsen K, Fladeby C, Nilsen M, Bjørnstad PM, Sundaram AYM, Ribarska T, Müller F, Gilfillan GD, Holberg-Petersen M (2021)
   Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory
   J Clin Virol, 141, 104906
   DOI 10.1016/j.jcv.2021.104906, PubMed 34273860

Publications 2020

1. Hoel H, Heggelund L, Reikvam DH, Stiksrud B, Ueland T, Michelsen AE, Otterdal K, Muller KE, Lind A, Muller F, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC, Trøseid M (2020)
   Elevated markers of gut leakage and inflammasome activation in COVID-19 patients with cardiac involvement
   J Intern Med, 289 (4), 523-531
   DOI 10.1111/joim.13178, PubMed 32976665
2. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P et al. (2020)
   Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
   Proc Natl Acad Sci U S A, 117 (40), 25018-25025
   DOI 10.1073/pnas.2010540117, PubMed 32943538
3. Jøntvedt Jørgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, Jenum S, Skeie LG, Nur S, Lind A, Opsand H, Enersen TB, Grøndahl R, Hermann A, Dudman S, Muller F, Ueland T, Mollnes TE, Aukrust P, Heggelund L, Holten AR, Dyrhol-Riise AM (2020)
   Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
   Sci Rep, 10 (1), 21697
   DOI 10.1038/s41598-020-78710-7, PubMed 33303843
4. Lorentzen EM, Henriksen S, Kaur A, Kro GB, Hammarström C, Hirsch HH, Midtvedt K, Rinaldo CH (2020)
   Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor
   Virol J, 17 (1), 5
   DOI 10.1186/s12985-019-1275-9, PubMed 31924245
5. Orlien SMS, Ahmed TA, Ismael NY, Berhe Belay N, Kran AB, Gundersen SG, Johannessen A (2020)
   Field performance of HBsAg rapid diagnostic tests in rural Ethiopia
   J Virol Methods, 289, 114061
   DOI 10.1016/j.jviromet.2020.114061, PubMed 33388369
6. Strand J, Gul KA, Erichsen HC, Lundman E, Berge MC, Trømborg AK, Sørgjerd LK, Ytre-Arne M, Hogner S, Halsne R, Gaup HJ, Osnes LT, Kro GAB, Sorte HS, Mørkrid L, Rowe AD, Tangeraas T, Jørgensen JV, Alme C, Bjørndalen TEH, Rønnestad AE, Lang AM, Rootwelt T, Buechner J, Øverland T et al. (2020)
   Second-Tier Next Generation Sequencing Integrated in Nationwide Newborn Screening Provides Rapid Molecular Diagnostics of Severe Combined Immunodeficiency
   Front Immunol, 11, 1417
   DOI 10.3389/fimmu.2020.01417, PubMed 32754152
7. Tollånes MC, Bakken Kran AM, Abildsnes E, Jenum PA, Breivik AC, Sandberg S (2020)
   Evaluation of eleven rapid tests for detection of antibodies against SARS-CoV-2
   Clin Chem Lab Med, 58 (9), 1595-1600
   DOI 10.1515/cclm-2020-0628, PubMed 32598303
8. Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2020)
   Elevated plasma sTIM-3 levels in patients with severe COVID-19
   J Allergy Clin Immunol, 147 (1), 92-98
   DOI 10.1016/j.jaci.2020.09.007, PubMed 32971109

Publications 2019

1. Bösl K, Ianevski A, Than TT, Andersen PI, Kuivanen S, Teppor M, Zusinaite E, Dumpis U, Vitkauskiene A, Cox RJ, Kallio-Kokko H, Bergqvist A, Tenson T, Merits A, Oksenych V, Bjørås M, Anthonsen MW, Shum D, Kaarbø M, Vapalahti O, Windisch MP, Superti-Furga G, Snijder B, Kainov D, Kandasamy RK (2019)
   Common Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis
   Front Immunol, 10, 2186
   DOI 10.3389/fimmu.2019.02186, PubMed 31636628
2. Hesstvedt L, Gaustad P, Müller F, Torp Andersen C, Brunborg C, Mylvaganam H, Leiva RA, Berdal JE, Egil Ranheim T, Johnsen BO, Falch BM, Grimnes G, Skogen V, Haarr E, Sandmo Lyngøy A, Wik Larssen K, Hannula R, Åsheim Hansen B, Nordøy I, Norwegian Fungal Network (2019)
   The impact of age on risk assessment, therapeutic practice and outcome in candidemia
   Infect Dis (Lond), 51 (6), 425-434
   DOI 10.1080/23744235.2019.1595709, PubMed 31010380
3. Olsen BC, Stubhaug TT, Berild JD (2019)
   A woman in her fifties with trismus and muscle spasms
   Tidsskr Nor Laegeforen, 139 (16)
   DOI 10.4045/tidsskr.18.0987, PubMed 31686491
4. Paraskevis D, Beloukas A, Stasinos K, Pantazis N, de Mendoza C, Bannert N, Meyer L, Zangerle R, Gill J, Prins M, d'Arminio Montforte A, Kran AB, Porter K, Touloumi G, CASCADE collaboration of EuroCoord (2019)
   HIV-1 molecular transmission clusters in nine European countries and Canada: association with demographic and clinical factors
   BMC Med, 17 (1), 4
   DOI 10.1186/s12916-018-1241-1, PubMed 30616632
5. Quist-Paulsen E, Kran AB, Lindland ES, Ellefsen K, Sandvik L, Dunlop O, Ormaasen V (2019)
   To what extent can clinical characteristics be used to distinguish encephalitis from encephalopathy of other causes? Results from a prospective observational study
   BMC Infect Dis, 19 (1), 80
   DOI 10.1186/s12879-018-3570-2, PubMed 30669985
6. Quist-Paulsen E, Ormaasen V, Kran AB, Dunlop O, Ueland PM, Ueland T, Eikeland R, Aukrust P, Nordenmark TH (2019)
   Encephalitis and aseptic meningitis: short-term and long-term outcome, quality of life and neuropsychological functioning
   Sci Rep, 9 (1), 16158
   DOI 10.1038/s41598-019-52570-2, PubMed 31695095

Publications 2018

1. Barlinn R, Dudman SG, Trogstad L, Gibory M, Muller F, Magnus P, Rollag H (2018)
   Maternal and congenital cytomegalovirus infections in a population-based pregnancy cohort study
   APMIS, 126 (12), 899-906
   DOI 10.1111/apm.12899, PubMed 30378168
2. Knudsen PK, Gammelsrud KW, Alfsnes K, Steinbakk M, Abrahamsen TG, Müller F, Bohlin J (2018)
   Transfer of a bla _CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses
   Sci Rep, 8 (1), 280
   DOI 10.1038/s41598-017-18659-2, PubMed 29321570
3. Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
   Donor-derived strongyloidiasis after organ transplantation in Norway
   Transpl Infect Dis, 21 (1), e13008
   DOI 10.1111/tid.13008, PubMed 30295406
4. Nordøy I, Hesstvedt L, Torp Andersen C, Mylvaganam H, Kols NI, Falch BM, Tofteland S, Müller F, Denning DW (2018)
   An Estimate of the Burden of Fungal Disease in Norway
   J Fungi (Basel), 4 (1)
   DOI 10.3390/jof4010029, PubMed 29466284
5. Olson A, Bannert N, Sönnerborg A, de Mendoza C, Price M, Zangerle R, Chaix ML, Prins M, Kran AB, Gill J, Paraskevis D, Porter K, for CASCADE Collaboration in EuroCoord (2018)
   Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort
   AIDS, 32 (2), 161-169
   DOI 10.1097/QAD.0000000000001689, PubMed 29112061
6. Quist-Paulsen E, Aukrust P, Kran AB, Dunlop O, Ormaasen V, Stiksrud B, Midttun Ø, Ueland T, Ueland PM, Mollnes TE, Dyrhol-Riise AM (2018)
   High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections
   J Neuroinflammation, 15 (1), 327
   DOI 10.1186/s12974-018-1366-3, PubMed 30470234
7. Winje BA, White R, Syre H, Skutlaberg DH, Oftung F, Mengshoel AT, Blix HS, Brantsæter AB, Holter EK, Handal N, Simonsen GS, Afset JE, Bakken Kran AM (2018)
   Stratification by interferon-γ release assay level predicts risk of incident TB
   Thorax, 73 (7), 652-661
   DOI 10.1136/thoraxjnl-2017-211147, PubMed 29622693

Publications 2017

1. Hole K, Størset E, Olastuen A, Haslemo T, Kro GB, Midtvedt K, Åsberg A, Molden E (2017)
   Recovery of CYP3A Phenotype after Kidney Transplantation
   Drug Metab Dispos, 45 (12), 1260-1265
   DOI 10.1124/dmd.117.078030, PubMed 28928137
2. Knudsen PK, Brandtzaeg P, Høiby EA, Bohlin J, Samuelsen Ø, Steinbakk M, Abrahamsen TG, Müller F, Gammelsrud KW (2017)
   Impact of extensive antibiotic treatment on faecal carriage of antibiotic-resistant enterobacteria in children in a low resistance prevalence setting
   PLoS One, 12 (11), e0187618
   DOI 10.1371/journal.pone.0187618, PubMed 29112974
3. Nguyen CB, Alsøe L, Lindvall JM, Sulheim D, Fagermoen E, Winger A, Kaarbø M, Nilsen H, Wyller VB (2017)
   Whole blood gene expression in adolescent chronic fatigue syndrome: an exploratory cross-sectional study suggesting altered B cell differentiation and survival
   J Transl Med, 15 (1), 102
   DOI 10.1186/s12967-017-1201-0, PubMed 28494812
4. Sand MK, Stubhaug TT, Jørstad ØK (2017)
   [Atypical optic neuritis]
   Tidsskr Nor Laegeforen, 137 (10), 731
   DOI 10.4045/tidsskr.16.1063, PubMed 28551973
5. Smeland TE, Müller F, Blomfeldt A, Stavem K, Aamot HV (2017)
   No associations established between single nucleotide polymorphisms in human Toll-like receptor 2 and Toll-interacting protein and Staphylococcus aureus bloodstream infections
   APMIS, 125 (10), 927-932
   DOI 10.1111/apm.12734, PubMed 28736863
6. Stav-Noraas TE, Edelmann RJ, Poulsen LC, Sundnes O, Phung D, Küchler AM, Müller F, Kamen AA, Haraldsen G, Kaarbø M, Hol J (2017)
   Endothelial IL-33 Expression Is Augmented by Adenoviral Activation of the DNA Damage Machinery
   J Immunol, 198 (8), 3318-3325
   DOI 10.4049/jimmunol.1600054, PubMed 28258201

Publications 2016

1. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S (2016)
   Correction for Blomfeldt et al., Molecular Characterization of Methicillin-Sensitive Staphylococcus aureus Isolates from Bacteremic Patients in a Norwegian University Hospital
   J Clin Microbiol, 54 (9), 2404
   DOI 10.1128/JCM.01436-16, PubMed 27578159
2. Holter JC, Ueland T, Jenum PA, Müller F, Brunborg C, Frøland SS, Aukrust P, Husebye E, Heggelund L (2016)
   Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study
   PLoS One, 11 (2), e0148741
   DOI 10.1371/journal.pone.0148741, PubMed 26849359
3. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
   A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
   Am J Gastroenterol, 111 (10), 1467-1475
   DOI 10.1038/ajg.2016.329, PubMed 27527747
4. Rosenstierne MW, Karlberg H, Bragstad K, Lindegren G, Stoltz ML, Salata C, Kran AM, Dudman SG, Mirazimi A, Fomsgaard A (2016)
   Rapid Bedside Inactivation of Ebola Virus for Safe Nucleic Acid Tests
   J Clin Microbiol, 54 (10), 2521-9
   DOI 10.1128/JCM.00346-16, PubMed 27466385
5. Siljan WW, Holter JC, Nymo SH, Schjalm C, Müller F, Jenum PA, Husebye E, Ueland T, Aukrust P, Mollnes TE, Heggelund L (2016)
   Circulating cell-free DNA is elevated in community-acquired bacterial pneumonia and predicts short-term outcome
   J Infect, 73 (4), 383-6
   DOI 10.1016/j.jinf.2016.07.011, PubMed 27452197
6. Stubhaug TT, Reiakvam OM, Stensvold CR, Hermansen NO, Holberg-Petersen M, Antal EA, Gaustad K, Førde IS, Heger B (2016)
   Fatal primary amoebic meningoencephalitis in a Norwegian tourist returning from Thailand
   JMM Case Rep, 3 (3), e005042
   DOI 10.1099/jmmcr.0.005042, PubMed 28348761

Publications 2015

1. Béziat V, Sleiman M, Goodridge JP, Kaarbø M, Liu LL, Rollag H, Ljunggren HG, Zimmer J, Malmberg KJ (2015)
   Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients
   Front Immunol, 6, 507
   DOI 10.3389/fimmu.2015.00507, PubMed 26500647
2. Broch K, Andreassen AK, Hopp E, Leren TP, Scott H, Müller F, Aakhus S, Gullestad L (2015)
   Results of comprehensive diagnostic work-up in 'idiopathic' dilated cardiomyopathy
   Open Heart, 2 (1), e000271
   DOI 10.1136/openhrt-2015-000271, PubMed 26468400
3. Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M et al. (2015)
   Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
   Clin Infect Dis, 62 (5), 655-663
   DOI 10.1093/cid/civ963, PubMed 26620652
4. Holter JC, Müller F, Bjørang O, Samdal HH, Marthinsen JB, Jenum PA, Ueland T, Frøland SS, Aukrust P, Husebye E, Heggelund L (2015)
   Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway
   BMC Infect Dis, 15, 64
   DOI 10.1186/s12879-015-0803-5, PubMed 25887603
5. Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2015)
   Correction: TCTP is an androgen-regulated gene implicated in prostate cancer
   PLoS One, 10 (5), e0128727
   DOI 10.1371/journal.pone.0128727, PubMed 25973603
6. Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, Chawla MS, Holberg-Petersen M, Vainio K, Dudman SG, Kran AM, Rojahn AE (2015)
   Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014
   Euro Surveill, 20 (10), 21062
   DOI 10.2807/1560-7917.es2015.20.10.21062, PubMed 25788251
7. Rollag H, Holter E, Muller F (2015)
   Hearing loss in children in Ostfold county 2000-09
   Tidsskr. Nor. Laegeforen., 135 (6), 511
8. Rollag H, Holter E, Müller F (2015)
   [Re: Hearing loss in children in Östfold county 2000-09]
   Tidsskr Nor Laegeforen, 135 (6), 513
   DOI 10.4045/tidsskr.15.0262, PubMed 25806741
9. Raastad R, Tvete IF, Abrahamsen TG, Berild D, Leegaard TM, Walberg M, Müller F (2015)
   A worrying trend in weight-adjusted paediatric antibiotic use in a Norwegian tertiary care hospital
   Acta Paediatr, 104 (7), 687-92
   DOI 10.1111/apa.12994, PubMed 25753620

Publications 2014

1. Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, Hungnes O, Dudman SG, Kran AM (2014)
   High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
   Influenza Other Respir Viruses, 9 (2), 59-63
   DOI 10.1111/irv.12300, PubMed 25534826
2. Brigtsen AK, Dedi L, Melby KK, Holberg-Petersen M, Radtke A, Lyng RV, Andresen LL, Jacobsen AF, Fugelseth D, Whitelaw A (2014)
   Comparison of PCR and serotyping of Group B Streptococcus in pregnant women: the Oslo GBS-study
   J Microbiol Methods, 108, 31-5
   DOI 10.1016/j.mimet.2014.11.001, PubMed 25447890
3. Fossum Moen AE, Holberg-Petersen M, Andresen LL, Blomfeldt A (2014)
   spa typing alone is not sufficient to demonstrate endemic establishment of meticillin-resistant Staphylococcus aureus in a low-prevalence country
   J Hosp Infect, 88 (2), 72-7
   DOI 10.1016/j.jhin.2014.06.008, PubMed 25085462
4. Kran AM (2014)
   [Local food at exotic vacation]
   Tidsskr Nor Laegeforen, 134 (2), 192-3
   DOI 10.4045/tidsskr.13.1372, PubMed 24477156
5. Sulheim D, Fagermoen E, Winger A, Andersen AM, Godang K, Müller F, Rowe PC, Saul JP, Skovlund E, Øie MG, Wyller VB (2014)
   Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-sectional and randomized clinical trial
   JAMA Pediatr, 168 (4), 351-60
   DOI 10.1001/jamapediatrics.2013.4647, PubMed 24493300

Publications 2013

1. Kaarbø M, Crane DI, Murrell WG (2013)
   RhoA regulation of cardiomyocyte differentiation
   ScientificWorldJournal, 2013, 491546
   DOI 10.1155/2013/491546, PubMed 23935420
2. Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K, for CASCADE Collaboration in EuroCoord (2013)
   Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration
   PLoS One, 8 (7), e71174
   DOI 10.1371/journal.pone.0071174, PubMed 23936260

Publications 2012

1. Aldrin M, Raastad R, Tvete IF, Berild D, Frigessi A, Leegaard T, Monnet DL, Walberg M, Müller F (2012)
   Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment
   Stat Med, 32 (8), 1407-18
   DOI 10.1002/sim.5636, PubMed 23027651
2. Blomfeldt A, Aamot HV, Eskesen AN, Müller F, Monecke S (2012)
   Molecular characterization of methicillin-sensitive Staphylococcus aureus isolates from bacteremic patients in a Norwegian University Hospital
   J Clin Microbiol, 51 (1), 345-7
   DOI 10.1128/JCM.02571-12, PubMed 23135934
3. Brantsæter AB, Johannessen A, Holberg-Petersen M, Sandvik L, Naman E, Kivuyo SL, Rollag H, Bruun JN, Kvale D (2012)
   Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
   Int J Infect Dis, 16 (12), e879-85
   DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
4. Harboe M, Garred P, Lindstad JK, Pharo A, Müller F, Stahl GL, Lambris JD, Mollnes TE (2012)
   The role of properdin in zymosan- and Escherichia coli-induced complement activation
   J Immunol, 189 (5), 2606-13
   DOI 10.4049/jimmunol.1200269, PubMed 22851705
5. Quist-Paulsen E, Kran AM, Dunlop O, Wilson J, Ormaasen V (2012)
   Infectious encephalitis: a description of a Norwegian cohort
   Scand J Infect Dis, 45 (3), 179-85
   DOI 10.3109/00365548.2012.719634, PubMed 23113672
6. Ranneberg-Nilsen T, Rollag H, Slettebakk R, Backe PH, Olsen Ø, Luna L, Bjørås M (2012)
   The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44
   PLoS One, 7 (3), e34119
   DOI 10.1371/journal.pone.0034119, PubMed 22479537
7. Rødland EK, Ueland T, Bjørnsen S, Sagen EL, Dahl CP, Naalsund A, Mollnes TE, Brosstad FR, Müller F, Aukrust P, Frøland SS (2012)
   Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
   BMC Infect Dis, 12, 144
   DOI 10.1186/1471-2334-12-144, PubMed 22731696
8. Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K, CASCADE collaboration in EuroCoord (2012)
   Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts
   Clin Infect Dis, 56 (6), 888-97
   DOI 10.1093/cid/cis1000, PubMed 23223594

Publications 2011

1. Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
   Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
   BMC Infect Dis, 11, 75
   DOI 10.1186/1471-2334-11-75, PubMed 21435254
2. Duri K, Müller F, Gumbo FZ, Kurewa NE, Rusakaniko S, Chirenje MZ, Mapingure MP, Stray-Pedersen B (2011)
   Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe
   BMC Infect Dis, 11, 7
   DOI 10.1186/1471-2334-11-7, PubMed 21211021
3. Kaarbø M, Ager-Wick E, Osenbroch PØ, Kilander A, Skinnes R, Müller F, Eide L (2011)
   Human cytomegalovirus infection increases mitochondrial biogenesis
   Mitochondrion, 11 (6), 935-45
   DOI 10.1016/j.mito.2011.08.008, PubMed 21907833
4. Lindqvist M, Isaksson B, Grub C, Jonassen TØ, Hällgren A (2011)
   Detection and characterisation of SCCmec remnants in multiresistant methicillin-susceptible Staphylococcus aureus causing a clonal outbreak in a Swedish county
   Eur J Clin Microbiol Infect Dis, 31 (2), 141-7
   DOI 10.1007/s10096-011-1286-y, PubMed 21590357
5. Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A (2011)
   Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients
   Transplantation, 92 (2), 217-23
   DOI 10.1097/TP.0b013e31821fad25, PubMed 21685829

Publications 2010

1. Andersen BM, Tollefsen T, Seljordslia B, Hochlin K, Syversen G, Jonassen TØ, Rasch M, Sandvik L (2010)
   Rapid MRSA test in exposed persons: costs and savings in hospitals
   J Infect, 60 (4), 293-9
   DOI 10.1016/j.jinf.2010.01.008, PubMed 20122959
2. Asberg A, Jardine AG, Bignamini AA, Rollag H, Pescovitz MD, Gahlemann CC, Humar A, Hartmann A, VICTOR Study Group (2010)
   Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients
   Am J Transplant, 10 (8), 1881-8
   DOI 10.1111/j.1600-6143.2010.03114.x, PubMed 20486914
3. Bratholm C, Johannessen A, Naman E, Gundersen SG, Kivuyo SL, Holberg-Petersen M, Ormaasen V, Bruun JN (2010)
   Drug resistance is widespread among children who receive long-term antiretroviral treatment at a rural Tanzanian hospital
   J Antimicrob Chemother, 65 (9), 1996-2000
   DOI 10.1093/jac/dkq234, PubMed 20576637
4. Duri K, Gumbo FZ, Kristiansen KI, Kurewa NE, Mapingure MP, Rusakaniko S, Chirenje MZ, Muller F, Stray-Pedersen B (2010)
   Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting
   Virol J, 7, 176
   DOI 10.1186/1743-422X-7-176, PubMed 20678190
5. Duri K, Soko W, Gumbo F, Kristiansen K, Mapingure M, Stray-Pedersen B, Muller F, BHAMC Group (2010)
   Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population
   AIDS Res Hum Retroviruses, 27 (4), 411-9
   DOI 10.1089/aid.2010.0142, PubMed 20969460
6. Grub C, Holberg-Petersen M, Medbø S, Andersen BM, Syversen G, Melby KK (2010)
   A multidrug-resistant, methicillin-susceptible strain of Staphylococcus aureus from a neonatal intensive care unit in Oslo, Norway
   Scand J Infect Dis, 42 (2), 148-51
   DOI 10.3109/00365540903334401, PubMed 19883164
7. Holberg-Petersen M, Jenum PA, Mannsåker T, Melby KK (2010)
   Comparison of PCR with culture applied on nasopharyngeal and throat swab specimens for the detection of Bordetella pertussis
   Scand J Infect Dis, 43 (3), 221-4
   DOI 10.3109/00365548.2010.538855, PubMed 21108541
8. Johannessen A, Holberg-Petersen M, Lövgaarden G, Naman E, Ormaasen V, Matee MI, Gundersen SG, Bruun JN (2010)
   HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania
   Antivir Ther, 15 (7), 1003-9
   DOI 10.3851/IMP1660, PubMed 21041915
9. Kran AM, Jonassen TO, Sommerfelt MA, Løvgården G, Sørensen B, Kvale D (2010)
   Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
   AIDS, 24 (17), 2609-18
   DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
10. Rødland EK, Ager-Wick E, Halvorsen B, Müller F, Frøland SS (2010)
    Toll like receptor 5 (TLR5) may be involved in the immunological response to Aspergillus fumigatus in vitro
    Med Mycol, 49 (4), 375-9
    DOI 10.3109/13693786.2010.531772, PubMed 21067314

Publications 2009

1. Johannessen A, Naman E, Kivuyo SL, Kasubi MJ, Holberg-Petersen M, Matee MI, Gundersen SG, Bruun JN (2009)
   Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania
   BMC Infect Dis, 9, 108
   DOI 10.1186/1471-2334-9-108, PubMed 19583845
2. Kran AM, Jonassen TØ, Sannes M, Jakobsen K, Lind A, Maeland A, Holberg-Petersen M (2009)
   Overestimation of human immunodeficiency virus type 1 load caused by the presence of cells in plasma from plasma preparation tubes
   J Clin Microbiol, 47 (7), 2170-4
   DOI 10.1128/JCM.00519-09, PubMed 19420166
3. Merckoll P, Jonassen TØ, Vad ME, Jeansson SL, Melby KK (2009)
   Bacteria, biofilm and honey: a study of the effects of honey on 'planktonic' and biofilm-embedded chronic wound bacteria
   Scand J Infect Dis, 41 (5), 341-7
   DOI 10.1080/00365540902849383, PubMed 19308800
4. Rødland EK, Ueland T, Pedersen TM, Halvorsen B, Muller F, Aukrust P, Frøland SS (2009)
   Activation of platelets by Aspergillus fumigatus and potential role of platelets in the immunopathogenesis of Aspergillosis
   Infect Immun, 78 (3), 1269-75
   DOI 10.1128/IAI.01091-09, PubMed 20008537

Publications 2008

1. Dalgard O, Bjøro K, Ring-Larsen H, Bjornsson E, Holberg-Petersen M, Skovlund E, Reichard O, Myrvang B, Sundelöf B, Ritland S, Hellum K, Frydén A, Florholmen J, Verbaan H, North-C Group (2008)
   Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
   Hepatology, 47 (1), 35-42
   DOI 10.1002/hep.21975, PubMed 17975791
2. Eskild A, Jeansson S, Jenum PA, Staff AC, Thadhani R, Karumanchi A, Vatten LJ (2008)
   Levels of angiogenic factors in pregnancy and post-partum bleeding
   Acta Obstet Gynecol Scand, 87 (10), 1081-3
   DOI 10.1080/00016340802415622, PubMed 18792843
3. Eskild A, Nilsen TI, Jeansson S, Jenum PA, Vatten LJ (2008)
   Serum levels of immunoglobulin E and the subsequent risk of pre-eclampsia: a population-based study
   Acta Obstet Gynecol Scand, 87 (3), 373-6
   DOI 10.1080/00016340701832687, PubMed 18307080
4. Maagaard A, Holberg-Petersen M, Løvgården G, Holm M, Pettersen FO, Kvale D (2008)
   Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
   J Infect Dis, 198 (10), 1474-81
   DOI 10.1086/592713, PubMed 18851688
5. Nyombi BM, Holm-Hansen C, Kristiansen KI, Bjune G, Müller F (2008)
   Prevalence of reverse transcriptase and protease mutations associated with antiretroviral drug resistance among drug-naïve HIV-1 infected pregnant women in Kagera and Kilimanjaro regions, Tanzania
   AIDS Res Ther, 5, 13
   DOI 10.1186/1742-6405-5-13, PubMed 18570675
6. Nyombi BM, Kristiansen KI, Bjune G, Müller F, Holm-Hansen C (2008)
   Diversity of human immunodeficiency virus type 1 subtypes in Kagera and Kilimanjaro regions, Tanzania
   AIDS Res Hum Retroviruses, 24 (6), 761-9
   DOI 10.1089/aid.2007.0311, PubMed 18507522
7. Nyombi BM, Nkya W, Barongo L, Bjune G, Kristiansen KI, Müller F, Holm-Hansen C (2008)
   Evolution of human immunodeficiency virus type 1 serotypes in northern Tanzania: a retrospective study
   APMIS, 116 (6), 507-14
   DOI 10.1111/j.1600-0463.2008.00996.x, PubMed 18754325
8. Ranneberg-Nilsen T, Dale HA, Luna L, Slettebakk R, Sundheim O, Rollag H, Bjørås M (2008)
   Characterization of human cytomegalovirus uracil DNA glycosylase (UL114) and its interaction with polymerase processivity factor (UL44)
   J Mol Biol, 381 (2), 276-88
   DOI 10.1016/j.jmb.2008.05.028, PubMed 18599070
9. Rødland EK, Mattingsdal M, Olstad OK, Ovstebø R, Kierulf P, Muller F, Frøland SS (2008)
   Expression of genes in normal human monocytes in response to Aspergillus fumigatus
   Med Mycol, 46 (4), 327-36
   DOI 10.1080/13693780701874507, PubMed 18415839
10. Vatten LJ, Nilsen TI, Juul A, Jeansson S, Jenum PA, Eskild A (2008)
    Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia
    Eur J Endocrinol, 158 (1), 101-5
    DOI 10.1530/EJE-07-0386, PubMed 18166823

Publications 2007

1. Anglès d'Auriac M, Refseth UH, Espelund M, Moi H, Størvold G, Jeansson S (2007)
   A new automated method for isolation of Chlamydia trachomatis from urine eliminates inhibition and increases robustness for NAAT systems
   J Microbiol Methods, 70 (3), 416-23
   DOI 10.1016/j.mimet.2007.05.017, PubMed 17610971
2. Blomberg B, Manji KP, Urassa WK, Tamim BS, Mwakagile DS, Jureen R, Msangi V, Tellevik MG, Holberg-Petersen M, Harthug S, Maselle SY, Langeland N (2007)
   Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study
   BMC Infect Dis, 7, 43
   DOI 10.1186/1471-2334-7-43, PubMed 17519011
3. Brantsaeter AB, Holberg-Petersen M, Jeansson S, Goplen AK, Bruun JN (2007)
   CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection - a retrospective autopsy based study
   BMC Infect Dis, 7, 127
   DOI 10.1186/1471-2334-7-127, PubMed 17986346
4. Maagaard A, Holberg-Petersen M, Torjesen PA, Bruun JN, Kvale D (2007)
   Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
   HIV Clin Trials, 8 (5), 345-53
   DOI 10.1310/hct0805-345, PubMed 17956836
5. Thilesen CM, Nicolaidis M, Lökebö JE, Falsen E, Jorde AT, Müller F (2007)
   Leptotrichia amnionii, an emerging pathogen of the female urogenital tract
   J Clin Microbiol, 45 (7), 2344-7
   DOI 10.1128/JCM.00167-07, PubMed 17522272
6. Vatten LJ, Eskild A, Nilsen TI, Jeansson S, Jenum PA, Staff AC (2007)
   Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia
   Am J Obstet Gynecol, 196 (3), 239.e1-6
   DOI 10.1016/j.ajog.2006.10.909, PubMed 17346536

Publications 2006

1. Cinek O, Witsø E, Jeansson S, Rasmussen T, Drevinek P, Wetlesen T, Vavrinec J, Grinde B, Rønningen KS (2006)
   Longitudinal observation of enterovirus and adenovirus in stool samples from Norwegian infants with the highest genetic risk of type 1 diabetes
   J Clin Virol, 35 (1), 33-40
   DOI 10.1016/j.jcv.2005.03.007, PubMed 15916916
2. Dudman SG, Trøseid M, Jonassen TØ, Steinbakk M (2006)
   [Whooping cough--an increasing problem in Norway]
   Tidsskr Nor Laegeforen, 126 (3), 305-8
   PubMed 16440035
3. Dyrøy E, Røst TH, Pettersen RJ, Halvorsen B, Gudbrandsen OA, Ueland T, Muna Z, Müller F, Nordrehaug JE, Aukrust P, Berge RK (2006)
   Tetradecylselenoacetic acid, a PPAR ligand with antioxidant, antiinflammatory, and hypolipidemic properties
   Arterioscler Thromb Vasc Biol, 27 (3), 628-34
   DOI 10.1161/01.ATV.0000255950.70774.d5, PubMed 17185614
4. Maagaard A, Holberg-Petersen M, Kollberg G, Oldfors A, Sandvik L, Bruun JN (2006)
   Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients
   Antivir Ther, 11 (5), 601-8
   PubMed 16964828
5. Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN (2006)
   Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients
   HIV Med, 7 (1), 53-8
   DOI 10.1111/j.1468-1293.2005.00336.x, PubMed 16313293
6. Ndongmo CB, Pieniazek D, Holberg-Petersen M, Holm-Hansen C, Zekeng L, Jeansson SL, Kaptue L, Kalish ML (2006)
   HIV genetic diversity in Cameroon: possible public health importance
   AIDS Res Hum Retroviruses, 22 (8), 812-6
   DOI 10.1089/aid.2006.22.812, PubMed 16910839
7. Ranneberg-Nilsen T, Bjørås M, Luna L, Slettebakk R, Dale HA, Seeberg E, Rollag H (2006)
   Human cytomegalovirus infection modulates DNA base excision repair in fibroblast cells
   Virology, 348 (2), 389-97
   DOI 10.1016/j.virol.2006.01.001, PubMed 16476462
8. Sandberg WJ, Yndestad A, Øie E, Smith C, Ueland T, Ovchinnikova O, Robertson AK, Müller F, Semb AG, Scholz H, Andreassen AK, Gullestad L, Damås JK, Frøland SS, Hansson GK, Halvorsen B, Aukrust P (2006)
   Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization
   Arterioscler Thromb Vasc Biol, 26 (4), 857-63
   DOI 10.1161/01.ATV.0000204334.48195.6a, PubMed 16424351

Publications 2005

1. Aukrust P, Luna L, Ueland T, Johansen RF, Müller F, Frøland SS, Seeberg EC, Bjørås M (2005)
   Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
   Blood, 105 (12), 4730-5
   DOI 10.1182/blood-2004-11-4272, PubMed 15705786
2. Hjelmesaeth J, Asberg A, Müller F, Hartmann A, Jenssen T (2005)
   New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection
   Curr Diabetes Rev, 1 (1), 1-10
   DOI 10.2174/1573399052952604, PubMed 18220577
3. Hjelmesaeth J, Müller F, Jenssen T, Rollag H, Sagedal S, Hartmann A (2005)
   Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta-cell damage
   Nephrol Dial Transplant, 20 (11), 2311-5
   DOI 10.1093/ndt/gfi033, PubMed 16046502
4. Trøseid M, Jonassen TØ, Steinbakk M (2005)
   Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma
   J Infect, 52 (1), e11-3
   DOI 10.1016/j.jinf.2005.04.014, PubMed 15936087

Publications 2004

1. Buzás K, Megyeri K, Miczák A, Fekete A, Degré M, Mándi Y, Rosztóczy I (2004)
   Different staphylococcal strains elicit different levels of production of T-helper 1-inducing cytokines
   Acta Microbiol Immunol Hung, 51 (3), 371-84
   DOI 10.1556/AMicr.51.2004.3.14, PubMed 15571076
2. Buzás K, Miczák A, Degré M, Megyeri K (2004)
   Rubella virus infection dysregulates the pattern of p63 expression
   APMIS, 112 (10), 656-62
   DOI 10.1111/j.1600-0463.2004.apm1121004.x, PubMed 15601317
3. Djurovic S, Iversen N, Jeansson S, Hoover F, Christensen G (2004)
   Comparison of nonviral transfection and adeno-associated viral transduction on cardiomyocytes
   Mol Biotechnol, 28 (1), 21-32
   DOI 10.1385/MB:28:1:21, PubMed 15456960
4. Halvorsen B, Waehre T, Scholz H, Clausen OP, von der Thüsen JH, Müller F, Heimli H, Tonstad S, Hall C, Frøland SS, Biessen EA, Damås JK, Aukrust P (2004)
   Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms
   J Lipid Res, 46 (2), 211-9
   DOI 10.1194/jlr.M400324-JLR200, PubMed 15547296
5. Heggelund L, Müller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Frøland SS (2004)
   Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication
   Clin Infect Dis, 39 (2), 264-9
   DOI 10.1086/421780, PubMed 15307037
6. Holm AM, Aukrust P, Damås JK, Müller F, Halvorsen B, Frøland SS (2004)
   Abnormal interleukin-7 function in common variable immunodeficiency
   Blood, 105 (7), 2887-90
   DOI 10.1182/blood-2004-06-2423, PubMed 15598813
7. Ormaasen V, Sandvik L, Asjø B, Holberg-Petersen M, Gaarder PI, Bruun JN (2004)
   An algorithm-based genotypic resistance score is associated with clinical outcome in HIV-1-infected adults on antiretroviral therapy
   HIV Med, 5 (6), 400-6
   DOI 10.1111/j.1468-1293.2004.00244.x, PubMed 15544691
8. Sagedal S, Hartmann A, Nordal KP, Osnes K, Leivestad T, Foss A, Degré M, Fauchald P, Rollag H (2004)
   Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival
   Kidney Int, 66 (1), 329-37
   DOI 10.1111/j.1523-1755.2004.00735.x, PubMed 15200441

Publications 2003

1. Aukrust P, Müller F, Svardal AM, Ueland T, Berge RK, Frøland SS (2003)
   Disturbed glutathione metabolism and decreased antioxidant levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy--potential immunomodulatory effects of antioxidants
   J Infect Dis, 188 (2), 232-8
   DOI 10.1086/376459, PubMed 12854078
2. Bucher A, Olsen P, Müller F (2003)
   [Community-acquired pneumonia--management in hospitals]
   Tidsskr Nor Laegeforen, 123 (6), 797-9
   PubMed 12693119
3. Christensen A, Nordbø SA, Jeansson S, Slørdahl S (2003)
   Lower respiratory tract infection caused by human metapneumovirus in two children: the first report of human metapneumovirus infection in Norway
   Scand J Infect Dis, 35 (10), 772-4
   DOI 10.1080/00365540310013306, PubMed 14606624
4. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H (2003)
   Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum
   Scand J Gastroenterol, 38 (8), 864-70
   DOI 10.1080/00365520310004542, PubMed 12940441
5. Harboe E, Reiersen R, Holberg-Petersen M, Natås OB (2003)
   [Transmission of methicillin resistant Staphylococcus aureus to primary health care workers in a home environment]
   Tidsskr Nor Laegeforen, 123 (3), 319-21
   PubMed 12640898
6. Holm AM, Aukrust P, Aandahl EM, Müller F, Taskén K, Frøland SS (2003)
   Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I
   J Immunol, 170 (11), 5772-7
   DOI 10.4049/jimmunol.170.11.5772, PubMed 12759461
7. Moen EM, Sagedal S, Bjøro K, Degré M, Opstad PK, Grinde B (2003)
   Effect of immune modulation on TT virus (TTV) and TTV-like-mini-virus (TLMV) viremia
   J Med Virol, 70 (1), 177-82
   DOI 10.1002/jmv.10356, PubMed 12629661
8. Msuya SE, Mbizvo E, Hussain A, Sam NE, Jeansson S, Stray-Pedersen B (2003)
   Seroprevalence and correlates of herpes simplex virus type 2 among urban Tanzanian women
   Sex Transm Dis, 30 (7), 588-92
   DOI 10.1097/00007435-200307000-00011, PubMed 12838089
9. Nordøy I, Rollag H, Lien E, Sindre H, Degré M, Aukrust P, Frøland SS, Müller F (2003)
   Cytomegalovirus infection induces production of human interleukin-10 in macrophages
   Eur J Clin Microbiol Infect Dis, 22 (12), 737-41
   DOI 10.1007/s10096-003-1028-x, PubMed 14610657
10. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2003)
    Prognostic value of changes in CD4 count and HIV RNA during the first six months on highly active antiretroviral therapy in chronic human immunodeficiency virus infection
    Scand J Infect Dis, 35 (6-7), 383-8
    DOI 10.1080/00365540310009716, PubMed 12953949
11. Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Asberg A, Degré M, Fauchald P, Rollag H (2003)
    Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
    Nephrol Dial Transplant, 18 (9), 1899-908
    DOI 10.1093/ndt/gfg302, PubMed 12937241
12. Synnestvedt M, Müller F, Gaustad P, Bucher A (2003)
    Recurrent group A Streptococcal genital infection after Puerperal sepsis
    Scand J Infect Dis, 35 (8), 509-10
    DOI 10.1080/00365540310013261, PubMed 14514155
13. Yndestad A, Holm AM, Müller F, Simonsen S, Frøland SS, Gullestad L, Aukrust P (2003)
    Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
    Cardiovasc Res, 60 (1), 141-6
    DOI 10.1016/s0008-6363(03)00362-6, PubMed 14522416

Publications 2002

1. Damås JK, Waehre T, Yndestad A, Ueland T, Müller F, Eiken HG, Holm AM, Halvorsen B, Frøland SS, Gullestad L, Aukrust P (2002)
   Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects
   Circulation, 106 (1), 36-42
   DOI 10.1161/01.cir.0000020001.09990.90, PubMed 12093767
2. Degré M (2002)
   Has cytomegalovirus infection any role in the development of atherosclerosis?
   Clin Microbiol Infect, 8 (4), 191-5
   DOI 10.1046/j.1469-0691.2002.00407.x, PubMed 12047409
3. Degre M (2002)
   Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
   Vox Sang., 83 (1), 87
   DOI 10.1046/j.1423-0410.2002.18515.x
4. Engelfriet CP, Reesink HW, Hernandez JM, Sauleda S, O'Riordan J, Prati D, Mozzi F, Lin CK, Cuypers HT, Vranckx R, Yoshizawa H, Tomono T, Flanagan P, Sabino EC, Politis C, Tegtmeier GE, Carasa MAV, Hewlett IK, Yu MYW, Epstein JS, Eglin R, Barbara J, Coste J, Cornillot C, Hyland CA et al. (2002)
   Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology
   Vox Sang., 82 (2), 87-111
   DOI 10.1046/j.0042-9007.2001.00147_1.x
5. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA (2002)
   Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women
   BJOG, 109 (9), 1030-5
   DOI 10.1111/j.1471-0528.2002.01534.x, PubMed 12269678
6. Eskild A, Jeansson S, Stray-Pedersen B, Jenum PA (2002)
   Herpes simplex virus type-2 infection in pregnancy: no risk of fetal death: results from a nested case-control study within 35,940 women
   BJOG, 109 (9), PII S1470-0328(02)01934-1-1035
   DOI 10.1016/S1470-0328(02)01934-1
7. Glosli H, Tronstad KJ, Wergedal H, Müller F, Svardal A, Aukrust P, Berge RK, Prydz H (2002)
   Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
   FASEB J, 16 (11), 1450-2
   DOI 10.1096/fj.01-0948fje, PubMed 12205044
8. Megyeri K, Mándi Y, Degré M, Rosztóczy I (2002)
   Induction of cytokine production by different Staphylococcal strains
   Cytokine, 19 (4), 206-12
   DOI 10.1006/cyto.2002.0876, PubMed 12297115
9. Ormaasen V, Bruun JN, Sandvik L, Holberg-Petersen M, Gaarder PI (2002)
   A search for optimal criteria in initiating antiretroviral therapy in chronic human immunodeficiency virus infection focusing on CD4 count and HIV RNA
   Scand J Infect Dis, 34 (12), 910-7
   DOI 10.1080/0036554021000026957, PubMed 12587624
10. Reesink HW, Engelfriet CP, Tegtmeier GE, O'Riordan J, Eglin R, Barbara JA, Flanagan P, Lin CK, Rawlinson W, Muylle L, Wendel S, Biagini S, Lazar AE, Krusius T, Alitupa E, Grillner L, Preiser W, Doerr HW, Brand A, Zupanska B, Brojer E, Degré M (2002)
    Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
    Vox Sang, 83 (1), 72-87
    DOI 10.1046/j.1423-0410.2002.t01-1-01851.x, PubMed 12100393
11. Rollag H, Sagedal S, Kristiansen KI, Kvale D, Holter E, Degré M, Nordal KP (2002)
    Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
    Clin Microbiol Infect, 8 (7), 431-4
    DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
12. Sagedal S, Nordal KP, Hartmann A, Sund S, Scott H, Degré M, Foss A, Leivestad T, Osnes K, Fauchald P, Rollag H (2002)
    The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients
    Am J Transplant, 2 (9), 850-6
    DOI 10.1034/j.1600-6143.2002.20907.x, PubMed 12392291

Publications 2001

1. Degré M, Kristiansen KI, Rollag H, Holter E, Nordal KP (2001)
   Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients
   Clin Microbiol Infect, 7 (5), 254-60
   DOI 10.1046/j.1198-743x.2001.00251.x, PubMed 11422252
2. Degré M, Ranneberg-Nilsen T, Beck S, Rollag H, Fiane AE (2001)
   Human cytomegalovirus productively infects porcine endothelial cells in vitro
   Transplantation, 72 (7), 1334-7
   DOI 10.1097/00007890-200110150-00028, PubMed 11602867
3. Jeansson S, Kvien TK (2001)
   Acanthamoeba polyphaga in rheumatoid arthritis: possibility for a chronic infection
   Scand J Immunol, 53 (6), 610-4
   DOI 10.1046/j.1365-3083.2001.00926.x, PubMed 11422910
4. Moens U, Van Ghelue M, Kristoffersen AK, Johansen B, Rekvig OP, Degré M, Rollag H (2001)
   Simian virus 40 large T-antigen, but not small T-antigen, trans-activates the human cytomegalovirus major immediate early promoter
   Virus Genes, 23 (2), 215-26
   DOI 10.1023/a:1011877112214, PubMed 11724277
5. Shadidi KR, Aarvak T, Jeansson S, Henriksen JE, Natvig JB, Thompson KM (2001)
   T-cell responses to viral, bacterial and protozoan antigens in rheumatoid inflammation. Selective migration of T cells to synovial tissue
   Rheumatology (Oxford), 40 (10), 1120-5
   DOI 10.1093/rheumatology/40.10.1120, PubMed 11600741
6. Trogstad LI, Eskild A, Bruu AL, Jeansson S, Jenum PA (2001)
   Is preeclampsia an infectious disease?
   Acta Obstet Gynecol Scand, 80 (11), 1036-8
   DOI 10.1034/j.1600-0412.2001.801112.x, PubMed 11703202

Publications 2000

1. Andenaes S, Lie A, Degré M (2000)
   Prevalence of hepatitis A, B, C, and E antibody in flying airline personnel
   Aviat Space Environ Med, 71 (12), 1178-80
   PubMed 11439715
2. Degré M (2000)
   [Poliomyelitis--a step closer to eradication]
   Tidsskr Nor Laegeforen, 120 (15), 1718
   PubMed 10904653
3. Eskild A, Jeansson S, Hagen JA, Jenum PA, Skrondal A (2000)
   Herpes simplex virus type-2 antibodies in pregnant women: the impact of the stage of pregnancy
   Epidemiol Infect, 125 (3), 685-92
   DOI 10.1017/s0950268800004702, PubMed 11218218
4. Eskild A, Samdal HH, Skaug K, Jeansson S, Stray-Pedersen B, Jenum PA (2000)
   [Hepatitis C virus among pregnant women in Norway--occurrence of antibodies and pregnancy outcome]
   Tidsskr Nor Laegeforen, 120 (9), 1006-8
   PubMed 10833956
5. Fiane AE, Mollnes TE, Degré M (2000)
   Pig endogenous retrovirus--a threat to clinical xenotransplantation?
   APMIS, 108 (4), 241-50
   DOI 10.1034/j.1600-0463.2000.d01-51.x, PubMed 10843410
6. Hungnes O, Jonassen TO, Jonassen CM, Grinde B (2000)
   Molecular epidemiology of viral infections. How sequence information helps us understand the evolution and dissemination of viruses
   APMIS, 108 (2), 81-97
   DOI 10.1034/j.1600-0463.2000.d01-31.x, PubMed 10737453
7. Rustscheff S, Maroti L, Holberg-Petersen M, Steinbakk M, Hoffner SE (2000)
   Mycobacterium interjectum: a new pathogen in humans?
   Scand J Infect Dis, 32 (5), 569-71
   DOI 10.1080/003655400458947, PubMed 11055671
8. Sagedal S, Nordal KP, Hartmann A, Degré M, Holter E, Foss A, Osnes K, Leivestad T, Fauchald P, Rollag H (2000)
   A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients
   Transplantation, 70 (8), 1166-74
   DOI 10.1097/00007890-200010270-00007, PubMed 11063335
9. Sindre H, Haraldsen G, Beck S, Hestdal K, Kvale D, Brandtzaeg P, Degré M, Rollag H (2000)
   Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
   Scand J Immunol, 51 (4), 354-60
   DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107
10. Sindre H, Rollag H, Degré M, Hestdal K (2000)
    Human cytomegalovirus induced inhibition of hematopoietic cell line growth is initiated by events taking place before translation of viral gene products
    Arch Virol, 145 (1), 99-111
    DOI 10.1007/s007050050008, PubMed 10664409
11. Sindre H, Rollag H, Olafsen MK, Degré M, Hestdal K (2000)
    Human cytomegalovirus induces apoptosis in the hematopoietic cell line MO7e
    APMIS, 108 (3), 223-30
    DOI 10.1034/j.1600-0463.2000.d01-48.x, PubMed 10752692

Publications 1999

1. Eskild A, Jeansson S, Jenum PA (1999)
   [Antibodies against Herpes simplex virus type 2 among pregnant women in Norway]
   Tidsskr Nor Laegeforen, 119 (16), 2323-6
   PubMed 10414195
2. Grabowska A, Jameson C, Laing P, Jeansson S, Sj Gren-Jansson E, Taylor J, Cunningham A, Irving WL (1999)
   Identification of type-specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, but not by those infected with HSV-1
   J Gen Virol, 80 ( Pt 7), 1789-1798
   DOI 10.1099/0022-1317-80-7-1789, PubMed 10423148
3. Holberg-Petersen M, Steinbakk M, Figenschau KJ, Jantzen E, Eng J, Melby KK (1999)
   Identification of clinical isolates of Mycobacterium spp. by sequence analysis of the 16S ribosomal RNA gene. Experience from a clinical laboratory
   APMIS, 107 (2), 231-9
   DOI 10.1111/j.1699-0463.1999.tb01549.x, PubMed 10225322
4. Skarin T, Becher R, Bucht A, Duvefelt K, Bohm S, Ranneberg-Nilsen T, Lilleaas EM, Schwarze PE, Toftgârd R (1999)
   Cis-acting sequences from the rat cytochrome P450 2B1 gene confer pulmonary and phenobarbital-inducible expression in transgenic mice
   Am J Respir Cell Mol Biol, 21 (2), 177-84
   DOI 10.1165/ajrcmb.21.2.3378, PubMed 10423399

Publications 1998

1. Bruun T, Kristoffersen AK, Rollag H, Beck S, Degré M (1998)
   Herpes simplex virus type 1 inhibits in vitro differentiation and selected functions of human blood-derived monocytes
   APMIS, 106 (12), 1194-203
   DOI 10.1111/j.1699-0463.1998.tb00277.x, PubMed 10052729
2. Bruun T, Kristoffersen AK, Rollag H, Degré M (1998)
   Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells
   APMIS, 106 (2), 305-14
   DOI 10.1111/j.1699-0463.1998.tb01351.x, PubMed 9531964
3. Eskild A, Jonassen TO, Heger B, Samuelsen SO, Grinde B (1998)
   The estimated impact of the CCR-5 delta32 gene deletion on HIV disease progression varies with study design. Oslo HIV Cohort Study Group
   AIDS, 12 (17), 2271-4
   DOI 10.1097/00002030-199817000-00007, PubMed 9863868
4. Flugsrud LB, Degré M (1998)
   [Poliomyelitis--the beginning of the end]
   Tidsskr Nor Laegeforen, 118 (13), 1997-8
   PubMed 9656781
5. Jenum PA, Holberg-Petersen M, Melby KK, Stray-Pedersen B (1998)
   Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience
   APMIS, 106 (7), 680-6
   DOI 10.1111/j.1699-0463.1998.tb00211.x, PubMed 9740505
6. Jonassen CM, Jonassen TO, Grinde B (1998)
   A common RNA motif in the 3' end of the genomes of astroviruses, avian infectious bronchitis virus and an equine rhinovirus
   J Gen Virol, 79 ( Pt 4), 715-8
   DOI 10.1099/0022-1317-79-4-715, PubMed 9568965
7. Pelloux H, Guy E, Angelici MC, Aspöck H, Bessières MH, Blatz R, Del Pezzo M, Girault V, Gratzl R, Holberg-Petersen M, Johnson J, Krüger D, Lappalainen M, Naessens A, Olsson M (1998)
   A second European collaborative study on polymerase chain reaction for Toxoplasma gondii, involving 15 teams
   FEMS Microbiol Lett, 165 (2), 231-7
   DOI 10.1111/j.1574-6968.1998.tb13151.x, PubMed 9742693
8. Rollag H, Sagedal S, Holter E, Degré M, Ariansen S, Nordal KP (1998)
   Diagnosis of cytomegalovirus infection in kidney transplant recipients by a quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leukocytes
   Eur J Clin Microbiol Infect Dis, 17 (2), 124-7
   DOI 10.1007/BF01682170, PubMed 9629980

Publications 1997

1. Holberg-Petersen M, Høgåsen AK, Høgåsen K, Abrahamsen TG, Degré M, Rollag H (1997)
   Infection with human cytomegalovirus (HCMV) stimulates monocyte production of complement factor 3
   Arch Virol, 142 (4), 689-98
   DOI 10.1007/s007050050111, PubMed 9170497
2. Holberg-Petersen M, Rollag H, Beck S, Degré M (1997)
   The effect of human cytomegalovirus on selected functions of peripheral blood monocytes
   APMIS, 105 (2), 89-98
   DOI 10.1111/j.1699-0463.1997.tb00546.x, PubMed 9113070
3. Kristoffersen AK, Johnsen JI, Seternes OM, Rollag H, Degré M, Traavik T (1997)
   The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus
   Virus Res, 52 (1), 61-71
   DOI 10.1016/s0168-1702(97)00100-7, PubMed 9453145
4. Kristoffersen AK, Sindre H, Mándi Y, Rollag H, Degré M (1997)
   Effect of adenovirus 2 on cellular gene activation in blood-derived monocytes and macrophages
   APMIS, 105 (5), 402-9
   DOI 10.1111/j.1699-0463.1997.tb00587.x, PubMed 9201242
5. Monceyron C, Grinde B, Jonassen TO (1997)
   Molecular characterisation of the 3'-end of the astrovirus genome
   Arch Virol, 142 (4), 699-706
   DOI 10.1007/s007050050112, PubMed 9170498

Publications 1996

1. Degré M (1996)
   Interferons and other cytokines in bacterial infections
   J Interferon Cytokine Res, 16 (6), 417-26
   DOI 10.1089/jir.1996.16.417, PubMed 8807494
2. Degré M (1996)
   Cytokines and bacterial infections
   Biotherapy, 8 (3-4), 219-28
   DOI 10.1007/BF01877208, PubMed 8813334
3. Dousset N, Moatti JP, Moatti N, Degré M, Eche B, Gasset G, Tixador R (1996)
   Influence of the environment in space on the biochemical characteristics of human low density lipoproteins
   Free Radic Res, 24 (1), 69-74
   DOI 10.3109/10715769609088001, PubMed 8747894
4. Grinde B, Jonassen TO (1996)
   [The HIV proteinase--a target for antiviral agents]
   Tidsskr Nor Laegeforen, 116 (24), 2908-11
   PubMed 8975409
5. Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS (1996)
   The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency
   APMIS, 104 (7-8), 539-48
   DOI 10.1111/j.1699-0463.1996.tb04909.x, PubMed 8920807
6. Holberg-Petersen M, Bukholm G, Haarr L, Langeland N, Degré M (1996)
   Human interferon reduces surface expression but not total production of herpes simplex virus type 1 glycoproteins gC and gE in heterologous hamster cells
   J Interferon Cytokine Res, 16 (9), 717-24
   DOI 10.1089/jir.1996.16.717, PubMed 8887056
7. Holberg-Petersen M, Rollag H, Beck S, Overli I, Tjønnfjord G, Abrahamsen TG, Degré M, Hestdal K (1996)
   Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro
   Blood, 88 (7), 2510-6
   DOI 10.1182/blood.V88.7.2510.bloodjournal8872510, PubMed 8839843
8. Sindre H, Tjøonnfjord GE, Rollag H, Ranneberg-Nilsen T, Veiby OP, Beck S, Degré M, Hestdal K (1996)
   Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells
   Blood, 88 (12), 4526-33
   DOI 10.1182/blood.V88.12.4526.bloodjournal88124526, PubMed 8977244

Publications 1995

1. Degré M (1995)
   [Infectious diseases--new and old, in new forms]
   Tidsskr Nor Laegeforen, 115 (23), 2875-6
   PubMed 7570504
2. Degré M (1995)
   [Transmissible spongiform encephalopathies--an unconventional contagious agent]
   Tidsskr Nor Laegeforen, 115 (25), 3137-40
   PubMed 8539696
3. Degré M, Bukholm G (1995)
   Orally administered interferon-gamma but not tumor necrosis factor-alpha suppress infection with Salmonella typhimurium in a mouse model
   J Biol Regul Homeost Agents, 9 (1), 15-20
   PubMed 8553903
4. Dueland AN, Ranneberg-Nilsen T, Degré M (1995)
   Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization
   Arch Virol, 140 (11), 2055-66
   DOI 10.1007/BF01322692, PubMed 7503701
5. Grinde B, Jonassen TO, Ushijima H (1995)
   Sensitive detection of group A rotaviruses by immunomagnetic separation and reverse transcription-polymerase chain reaction
   J Virol Methods, 55 (3), 327-38
   DOI 10.1016/0166-0934(95)00070-x, PubMed 8609198
6. Moatti JP, Dousset N, Moatti N, Degre M, Eche B, Gasset G, Tixador R (1995)
   ESA's Biopan 1--"Vitamin" experiment preliminary results
   Acta Astronaut, 36 (8-12), 527-33
   DOI 10.1016/0094-5765(95)00138-7, PubMed 11540984
7. Modalsli KR, Bukholm G, Holberg-Petersen M, Degré M (1995)
   Shigella flexneri adherence to and multiplication in coxsackie B1 virus-infected HEp-2 cells
   APMIS, 103 (4), 254-60
   DOI 10.1111/j.1699-0463.1995.tb01103.x, PubMed 7612255
8. Trybala E, Bergström T, Olofsson S, Svennerholm B, Jeansson S (1995)
   An evaluation of a hemagglutination-inhibition test for the detection of antibodies to herpes simplex virus type 1
   Clin Diagn Virol, 3 (2), 191-201
   DOI 10.1016/0928-0197(94)00030-x, PubMed 15566801
9. Ulstrup JC, Jeansson S, Wiker HG, Harboe M (1995)
   Relationship of secretion pattern and MPB70 homology with osteoblast-specific factor 2 to osteitis following Mycobacterium bovis BCG vaccination
   Infect Immun, 63 (2), 672-5
   DOI 10.1128/iai.63.2.672-675.1995, PubMed 7822037

Publications 1994

1. Degré M, Beck S (1994)
   Anti-HIV activity of dideoxynucleosides, foscarnet and fusidic acid is potentiated by human leukocyte interferon in blood-derived macrophages
   Chemotherapy, 40 (3), 201-8
   DOI 10.1159/000239193, PubMed 7515781
2. Degré M, Bukholm G, Holter E, Müller F, Rollag H (1994)
   Rapid detection of cytomegalovirus infection in immunocompromised patients
   Eur J Clin Microbiol Infect Dis, 13 (8), 668-70
   DOI 10.1007/BF01973997, PubMed 7813501
3. Holberg-Petersen M, Bukholm G, Rollag H, Degré M (1994)
   Infection with human cytomegalovirus enhances bacterial adhesiveness and invasiveness in permissive and semipermissive cells
   APMIS, 102 (9), 703-10
   DOI 10.1111/j.1699-0463.1994.tb05223.x, PubMed 7946274
4. Skaug K, Jonassen TO, Figenschau KJ (1994)
   [New cases of HIV infection. Estimation of the time of transmission]
   Tidsskr Nor Laegeforen, 114 (18), 2099-101
   PubMed 7992264
5. Tigalonova M, Bjerke JR, Gallati H, Degré M, Jablonska S, Majewski S, Matre R (1994)
   Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy
   Acta Derm Venereol Suppl (Stockh), 186, 25-7
   DOI 10.2340/000155551862527, PubMed 8073829
6. TIGALONOVA M, BJERKE JR, GALLATI H, DEGRE M, JABLONSKA S, MAJEWSKI S, MATRE R (1994)
   SERUM LEVELS OF INTERFERONS AND TNF-ALPHA ARE NOT CORRELATED TO PSORIASIS ACTIVITY AND THERAPY
   Acta Derm.-Venereol., 74 186, 25-27

Publications 1993

1. Li H, Ulstrup JC, Jonassen TO, Melby K, Nagai S, Harboe M (1993)
   Evidence for absence of the MPB64 gene in some substrains of Mycobacterium bovis BCG
   Infect Immun, 61 (5), 1730-4
   DOI 10.1128/iai.61.5.1730-1734.1993, PubMed 8478061
2. Modalsli KR, Mikalsen SO, Bukholm G, Degré M (1993)
   Microinjection of HEp-2 cells with coxsackie B1 virus RNA enhances invasiveness of Shigella flexneri only after prestimulation with UV-inactivated virus
   APMIS, 101 (8), 602-6
   DOI 10.1111/j.1699-0463.1993.tb00153.x, PubMed 8217113
3. Skaug K, Li H, Jonassen TO, Larsen J, Figenschau KJ (1993)
   Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients
   Vox Sang, 64 (4), 215-9
   DOI 10.1111/j.1423-0410.1993.tb03058.x, PubMed 7685969
4. Stenseth AM, Rollag H, Degré M (1993)
   Effect of in vitro acyclovir treatment on selected functions of blood-derived macrophages
   Chemotherapy, 39 (3), 197-202
   DOI 10.1159/000239126, PubMed 8508690

Publications 1992

1. Bell H, Raknerud N, Try K, Jonassen TO, Skaug K, Størvold G, Roald B, Kuo G (1992)
   [Chronic hepatitis C. Experience with 50 patients]
   Tidsskr Nor Laegeforen, 112 (23), 2953-7
   PubMed 1329264
2. Degré M (1992)
   [Prevention and treatment of influenza]
   Tidsskr Nor Laegeforen, 112 (16), 2052
   PubMed 1523619
3. Degré M, Beck S, Rollag H (1992)
   Interferon-gamma may enhance infection of blood-derived macrophages with HIV-1 in the presence of HIV-positive serum
   APMIS, 100 (5), 465-9
   DOI 10.1111/j.1699-0463.1992.tb00898.x, PubMed 1586484
4. Gundersen SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Deelder AM (1992)
   Quantitative detection of schistosomal circulating anodic antigen by a magnetic bead antigen capture enzyme-linked immunosorbent assay (MBAC-EIA) before and after mass chemotherapy
   Trans R Soc Trop Med Hyg, 86 (2), 175-8
   DOI 10.1016/0035-9203(92)90559-u, PubMed 1440781
5. Gundersen SG, Haagensen I, Jonassen TO, Figenschau KJ, de Jonge N, Deelder AM (1992)
   Magnetic bead antigen capture enzyme-linked immunoassay in microtitre trays for rapid detection of schistosomal circulating anodic antigen
   J Immunol Methods, 148 (1-2), 1-8
   DOI 10.1016/0022-1759(92)90151-i, PubMed 1564319
6. Modalsli K, Bukholm G, Degré M (1992)
   Interferon treatment reduced adherence, invasiveness and intracellular multiplication of Shigella flexneri in coxsackie B1 virus-infected cells
   J Biol Regul Homeost Agents, 6 (2), 35-45
   PubMed 1329437
7. Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
   Correlation between Coxsackie B1 virus replication and enhanced invasiveness of Shigella flexneri
   APMIS, 100 (3), 237-45
   DOI 10.1111/j.1699-0463.1992.tb00866.x, PubMed 1314061
8. Modalsli K, Bukholm G, Mikalsen SO, Degré M (1992)
   Coxsackie B1 virus-induced changes in cell membrane-associated functions are not responsible for altered sensitivity to bacterial invasiveness
   Arch Virol, 124 (3-4), 321-32
   DOI 10.1007/BF01309812, PubMed 1318709
9. Müller F, Holberg-Petersen M, Rollag H, Degré M, Brandtzaeg P, Frøland SS (1992)
   Nonspecific oral immunity in individuals with HIV infection
   J Acquir Immune Defic Syndr (1988), 5 (1), 46-51
   PubMed 1371157

Publications 1991

1. Degré M (1991)
   [Antiviral agents for the systemic treatment of herpesvirus infections]
   Tidsskr Nor Laegeforen, 111 (21), 2663-4
   PubMed 1658971
2. Degré M (1991)
   [Virologic rapid diagnosis]
   Tidsskr Nor Laegeforen, 111 (15), 1866
   PubMed 1853322
3. Degré M, Rollag H, Holter E, Tønjum T, Krajci Z, Bukholm G (1991)
   [Diagnosis of cytomegalovirus infections in hospitalized patients]
   Tidsskr Nor Laegeforen, 111 (28), 3401-4
   PubMed 1665258
4. Holberg-Petersen M, Böhmer E, Namork E, Degré M (1991)
   Effect of interferon treatment on expression of gC and gE glycoproteins in herpes simplex virus-infected cells
   APMIS, 99 (4), 307-15
   DOI 10.1111/j.1699-0463.1991.tb05154.x, PubMed 1645168
5. Mándi Y, Endrész V, Krenács L, Régely K, Degré M, Béládi I (1991)
   Tumor necrosis factor production by human granulocytes
   Int Arch Allergy Appl Immunol, 96 (2), 102-6
   DOI 10.1159/000235479, PubMed 1769740
6. Modalsli KR, Bukholm G, Mikalsen SO, Degré M (1991)
   Microinjected Coxsackie B1 virus does not replicate in HEp-2 cells
   Virology, 185 (2), 888-90
   DOI 10.1016/0042-6822(91)90566-t, PubMed 1660207
7. Rollag H, Patou G, Pattison JR, Degré M, Evensen SA, Fröland SS, Glomstein A (1991)
   Prevalence of antibodies against parvovirus B19 in Norwegians with congenital coagulation factor defects treated with plasma products from small donor pools
   Scand J Infect Dis, 23 (6), 675-9
   DOI 10.3109/00365549109024292, PubMed 1815327

Publications 1990

1. Bukholm G, Degré M, Whitaker-Dowling P (1990)
   Interferon treatment reduces endocytosis of virus and facultatively intracellular bacteria in various cell lines
   J Interferon Res, 10 (1), 83-9
   DOI 10.1089/jir.1990.10.83, PubMed 1691770
2. Dahl-Hansen E, Siebke JC, Frøland SS, Degré M (1990)
   Immunogenicity of yeast-derived hepatitis B vaccine from two different producers
   Epidemiol Infect, 104 (1), 143-9
   DOI 10.1017/s0950268800054625, PubMed 2137785
3. Degré M (1990)
   [Latent and activated viral infections]
   Tidsskr Nor Laegeforen, 110 (21), 2747-8
   PubMed 2219044
4. Degré M, Bukholm G (1990)
   Effect of tumor necrosis factor-alpha on infection with Salmonella typhimurium in a mouse model
   J Biol Regul Homeost Agents, 4 (4), 157-61
   PubMed 2128989
5. Modalsli K, Bukholm G, Degré M (1990)
   Coxsackie B1 virus infection enhances the bacterial invasiveness, the phagocytosis and the membrane permeability in HEp-2 cells
   APMIS, 98 (6), 489-95
   DOI 10.1111/j.1699-0463.1990.tb01061.x, PubMed 2166540

Publications 1989

1. Brinchmann JE, Gaudernack G, Thorsby E, Jonassen TO, Vartdal F (1989)
   Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells
   J Virol Methods, 25 (3), 293-300
   DOI 10.1016/0166-0934(89)90056-6, PubMed 2573612
2. Degré M, Bukholm G, Czarniecki CW (1989)
   In vitro treatment of HEp-2 cells with human tumor necrosis factor-alpha and human interferons reduces invasiveness of Salmonella typhimurium
   J Biol Regul Homeost Agents, 3 (1), 1-7
   PubMed 2472042
3. Maehlen T, Degré M (1989)
   Lack of activity of fusidic acid against human immunodeficiency virus in monocytes
   Antimicrob Agents Chemother, 33 (5), 680-3
   DOI 10.1128/AAC.33.5.680, PubMed 2473711
4. Mándi Y, Degré M, Béládi I (1989)
   Involvement of tumor necrosis factor in human granulocyte-mediated killing of WEHI 164 cells
   Int Arch Allergy Appl Immunol, 90 (4), 411-3
   DOI 10.1159/000235063, PubMed 2613348
5. Rollag H, Degré M (1989)
   Phagocytic activity and protein content of human monocytes cultivated in the presence of various homologous interferon preparations
   J Biol Regul Homeost Agents, 3 (1), 39-44
   PubMed 2472044
6. Schmidt H, Bukholm G, Holberg-Petersen M (1989)
   Adhesiveness and invasiveness of staphylococcal species in a cell culture model
   APMIS, 97 (7), 655-60
   DOI 10.1111/j.1699-0463.1989.tb00457.x, PubMed 2751900

Publications 1988

1. Bukholm G, Bergh M, Degré M (1988)
   Interferon treatment of HEp-2 cells alters the adhesive ability of Pseudomonas aeruginosa
   APMIS, 96 (11), 1043-8
   DOI 10.1111/j.1699-0463.1988.tb00979.x, PubMed 2461717
2. Bukholm G, Bjørnland K, Ellekjaer H, Berdal BP, Degré M (1988)
   Vesicular stomatitis virus infection enhances invasiveness of Salmonella typhimurium
   APMIS, 96 (5), 400-6
   DOI 10.1111/j.1699-0463.1988.tb05322.x, PubMed 2837253
3. Bukholm G, Degré M (1988)
   Shiga toxin inhibits the anti-invasive effect of interferons
   J Infect Dis, 157 (4), 849-50
   DOI 10.1093/infdis/157.4.849, PubMed 2450154
4. Degré M, Bukholm G (1988)
   Effects of interferon and tumour necrosis factor on development of intracellular bacterial infections
   Acta Microbiol Hung, 35 (4), 405-10
   PubMed 2469282
5. Ekgren J, Norling BK, Degre M, Midtvedt T (1988)
   Comparison of tinidazole given as a single dose and on 2 consecutive days for the treatment of nonspecific bacterial vaginosis
   Gynecol Obstet Invest, 26 (4), 313-7
   DOI 10.1159/000293712, PubMed 3068098
6. Oftung F, Mustafa AS, Shinnick TM, Houghten RA, Kvalheim G, Degre M, Lundin KE, Godal T (1988)
   Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells
   J Immunol, 141 (8), 2749-54
   PubMed 2459228
7. Rollag H, Degré M (1988)
   Effect of recombinant interferon-gamma on protein content, phagocytic, and cytotoxic activity of mouse peritoneal macrophages
   J Interferon Res, 8 (2), 169-78
   DOI 10.1089/jir.1988.8.169, PubMed 3132510
8. Skar AG, Middeldorp J, Gundersen T, Rollag H, Degrè M (1988)
   Rapid diagnosis of genital herpes simplex infection by an indirect ELISA method
   NIPH Ann, 11 (2), 59-65
   PubMed 3247065

Publications 1987

1. Austgulen R, Nissen-Meyer J, Degré M, Espevik T (1987)
   Monocyte-derived influence on growth of normal human fibroblasts. The contribution of tumour necrosis factor to growth inhibition
   Scand J Immunol, 26 (2), 175-85
   DOI 10.1111/j.1365-3083.1987.tb02249.x, PubMed 3114873
2. Bukholm G, Bergh M, Degré M (1987)
   Interferon-induced protein synthesis inhibits endocytosis of bacteria in epithelial cells
   J Interferon Res, 7 (4), 409-17
   DOI 10.1089/jir.1987.7.409, PubMed 3312425
3. Grinde B, Jonassen TO (1987)
   Methionine is a regulator of starvation-induced proteolysis in Tetrahymena
   Exp Cell Res, 173 (2), 496-503
   DOI 10.1016/0014-4827(87)90289-8, PubMed 3691671
4. Livden JK, Bjerke JR, Degre M, Krogh HK, Matre R (1987)
   The significance of interferon in photoimmunology
   Acta Derm Venereol Suppl (Stockh), 134, 43-6
   PubMed 2451386
5. Livden JK, Bjerke JR, Degre M, Matre R (1987)
   Effect of UV radiation on interferon, immunoglobulins and complement components in serum from healthy individuals
   Photodermatol, 4 (6), 296-301
   PubMed 2451236

Publications 1986

1. Bruserud O, Degré M, Thorsby E (1986)
   Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin
   Acta Pathol Microbiol Immunol Scand C, 94 (2), 51-5
   DOI 10.1111/j.1699-0463.1986.tb02089.x, PubMed 3090859
2. Bukholm G, Modalsli K, Degré M (1986)
   Effect of measles-virus infection and interferon treatment on invasiveness of Shigella flexneri in HEp2-cell cultures
   J Med Microbiol, 22 (4), 335-41
   DOI 10.1099/00222615-22-4-335, PubMed 3098977
3. Degré M (1986)
   Interaction between viral and bacterial infections in the respiratory tract
   Scand J Infect Dis Suppl, 49, 140-5
   PubMed 2434989
4. DEGRE M (1986)
   INTERACTION BETWEEN VIRAL AND BACTERIAL-INFECTIONS IN THE RESPIRATORY-TRACT
   Scand. J. Infect. Dis. (49), 140-145
5. Degré M, Holberg-Petersen M (1986)
   Influence of a carcinogenic agent, 7.12 dimethylbenz (alpha) anthracene (DMBA), on production of interferon alpha/beta in murine and human cells
   Acta Pathol Microbiol Immunol Scand B, 94 (1), 51-5
   DOI 10.1111/j.1699-0463.1986.tb03019.x, PubMed 3014815
6. Jonassen TO, Grinde B (1986)
   Proteolytic response to nutritional step-down in Tetrahymena
   Exp Cell Res, 163 (1), 165-74
   DOI 10.1016/0014-4827(86)90569-0, PubMed 3510885
7. Livden JK, Bjerke JR, Degre M, Matre R (1986)
   The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis
   Br J Dermatol, 114 (2), 217-25
   DOI 10.1111/j.1365-2133.1986.tb02800.x, PubMed 2418865
8. Mustafa AS, Kvalheim G, Degre M, Godal T (1986)
   Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production
   Infect Immun, 53 (3), 491-7
   DOI 10.1128/iai.53.3.491-497.1986, PubMed 2427449
9. Siebke JC, von der Lippe B, Hansson BG, Nordenfelt E, Degré M (1986)
   Prevalence and clinical effects of delta agent. Infections in Norwegian population subgroups
   Scand J Infect Dis, 18 (1), 33-6
   DOI 10.3109/00365548609032303, PubMed 3961420
10. von der Lippe E, Frøland S, Rollag H, Degre M (1986)
    Effect of fibroblast interferon and recombinant gamma interferon on zymosan-induced nitroblue tetrazolium reduction in mouse peritoneal macrophages
    Acta Pathol Microbiol Immunol Scand B, 94 (5), 343-6
    DOI 10.1111/j.1699-0463.1986.tb03064.x, PubMed 3098042

Publications 1985

1. BREDE HD, EHRENGUT W, PLOTKIN SA, SPIESS H, SCHILD G, GERSHON AA, DEGRE M, MENSER M, THIRY L, EGGERS HJ, SIMON C, PREBLUD SR, AMBROSCH F, MORRONDO RN, NICHOLSON K, BOUGHTON CR, DUDGEON JA, ENDERS G (1985)
   THE NEED FOR IMMUNIZATION AGAINST VARICELLA - GENERAL DISCUSSION
   Postgrad. Med. J., 61 4, 31-34
2. Bukholm G, Degré M (1985)
   Effect of human gamma interferon on invasiveness of Salmonella typhimurium in HEp-2 cell cultures
   J Interferon Res, 5 (1), 45-53
   DOI 10.1089/jir.1985.5.45, PubMed 3921632
3. Bukholm G, Holberg-Petersen M, Degré M (1985)
   Invasiveness of Salmonella typhimurium in HEp-2 cell cultures pretreated with UV-inactivated coxsackie virus
   Acta Pathol Microbiol Immunol Scand B, 93 (1), 61-5
   DOI 10.1111/j.1699-0463.1985.tb02852.x, PubMed 2984878
4. Kjeldsberg E, Rollag H, Lund H, Holberg-Pettersen M, Degré M (1985)
   Effect of gamma interferon on spreading of mouse peritoneal macrophages on solid surfaces
   Acta Pathol Microbiol Immunol Scand B, 93 (3), 165-70
   DOI 10.1111/j.1699-0463.1985.tb02871.x, PubMed 3929557
5. Qvigstad E, Onsrud M, Degré M, Skaug K (1985)
   Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinoma
   Gynecol Oncol, 20 (2), 184-9
   DOI 10.1016/0090-8258(85)90140-4, PubMed 2982703
6. Slørdahl SH, Wiger D, Strømøy T, Degre M, Thørsby E, Lie SO (1985)
   Vaccination of children with malignant disease against varicella
   Postgrad Med J, 61 Suppl 4, 85-92
   PubMed 3014484

Publications 1984

1. BJERKE JR, DEGRE M, HAUKENES G, KROGH HK, LIVDEN JK, MATRE R (1984)
   T-CELLS, INTERFERONS AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
   Acta Derm.-Venereol. (113), 29-33
2. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1984)
   ACID-LABILE ALPHA-INTERFERON
   N. Engl. J. Med., 310 (14), 922-923
3. Bukholm G, Berdal BP, Haug C, Degré M (1984)
   Mouse fibroblast interferon modifies Salmonella typhimurium infection in infant mice
   Infect Immun, 45 (1), 62-6
   DOI 10.1128/iai.45.1.62-66.1984, PubMed 6376362
4. Bukholm G, Degré M (1984)
   Invasiveness of Salmonella typhimurium in HEp-2 cell cultures preinfected with Coxsackie B 1 virus
   Acta Pathol Microbiol Immunol Scand B, 92 (1), 45-51
   DOI 10.1111/j.1699-0463.1984.tb02792.x, PubMed 6324532
5. Degré M (1984)
   [Interferon--recent developments at basic and application levels]
   Nord Med, 99 (3), 76-7, 71
   PubMed 6203095
6. Degré M, Siebke JC, Frøland SS (1984)
   [Prevention of hepatitis B by vaccination]
   Tidsskr Nor Laegeforen, 104 (27), 1906-7
   PubMed 6515608
7. Rollag H, Degré M, Sonnenfeld G (1984)
   Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages
   Scand J Immunol, 20 (2), 149-55
   DOI 10.1111/j.1365-3083.1984.tb00988.x, PubMed 6236548
8. Siebke JC, Degré M (1984)
   Prevalence of viral hepatitis in the staff in Norwegian anaesthesiology units
   Acta Anaesthesiol Scand, 28 (5), 549-53
   DOI 10.1111/j.1399-6576.1984.tb02117.x, PubMed 6496015
9. Slørdahl SH, Lie SO, Wiger D, Winsnes R, Degre M, Strømøy T, Thorsby E (1984)
   [Vaccination of immunosuppressed children against varicella]
   Tidsskr Nor Laegeforen, 104 (30), 2086-9
   PubMed 6095484
10. Vinje O, Førre O, Degre M, Møller P (1984)
    Natural killer (NK) cell activity of peripheral blood lymphocytes from patients with Bechterew's syndrome (ankylosing spondylitis)
    Scand J Rheumatol, 13 (4), 297-302
    DOI 10.3109/03009748409111299, PubMed 6441246

Publications 1983

1. Bjerke JR, Haukenes G, Livden JK, Matre R, Degré M (1983)
   Activated T lymphocytes, interferon, and retrovirus-like particles in psoriatic lesions
   Arch Dermatol, 119 (12), 955-6
   PubMed 6197033
2. BJERKE JR, HAUKENES G, LIVDEN JK, MATRE R, DEGRE M (1983)
   ACTIVATED LYMPHOCYTES-T, INTERFERON, AND RETROVIRUS-LIKE PARTICLES IN PSORIATIC LESIONS
   Arch. Dermatol., 119 (12), 955-956
3. Bjerke JR, Livden JK, Degré M, Matre R (1983)
   Interferon in suction blister fluid from psoriatic lesions
   Br J Dermatol, 108 (3), 295-9
   DOI 10.1111/j.1365-2133.1983.tb03967.x, PubMed 6187354
4. Bukholm G, Degré M (1983)
   Effect of human leukocyte interferon on invasiveness of Salmonella species in HEp-2 cell cultures
   Infect Immun, 42 (3), 1198-202
   DOI 10.1128/iai.42.3.1198-1202.1983, PubMed 6358041
5. Degré M (1983)
   [Vaccines against cytomegalovirus infection]
   Tidsskr Nor Laegeforen, 103 (3), 236-7
   PubMed 6302943
6. Degré M (1983)
   [Immunological defense factors against viral infections]
   Tidsskr Nor Laegeforen, 103 (3), 177-8
   PubMed 6845309
7. Degré M, Belsnes K, Rollag H, Beck S, Sonnenfeld G (1983)
   Influence of the genotype of mice on the effect of interferon on phagocytic activity of macrophages
   Proc Soc Exp Biol Med, 173 (1), 27-31
   DOI 10.3181/00379727-173-41604, PubMed 6344094
8. Degré M, Glasgow LA (1983)
   Establishment and preliminary characterization of a cell line persistently infected with Newcastle disease virus
   Acta Pathol Microbiol Immunol Scand B, 91 (6), 389-94
   DOI 10.1111/j.1699-0463.1983.tb00065.x, PubMed 6324529
9. DeGré M, Mellbye OJ, Clarke-Jenssen O (1983)
   Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders
   Ann Rheum Dis, 42 (6), 672-6
   DOI 10.1136/ard.42.6.672, PubMed 6418086
10. Ritland S, Blomhoff JP, Degre M (1983)
    [Hepatitis B virus--hepatocellular carcinoma]
    Tidsskr Nor Laegeforen, 103 (33), 2237-9
    PubMed 6318382

Publications 1982

1. DEGRE M (1982)
   BACTERIAL-MENINGITIS AFTER INFLUENZA
   Lancet, 1 (8275), 804
2. Degré M, Rollag H (1982)
   Effect of murine beta-interferon preparation on phagocytosis and cyclic AMP levels in mouse peritoneal macrophages
   J Interferon Res, 2 (2), 151-7
   DOI 10.1089/jir.1982.2.151, PubMed 6288813
3. Degré M, Rollag H, Kjeldsberg E (1982)
   Morphological parameters of the effect of interferon on mouse peritoneal macrophages
   Philos Trans R Soc Lond B Biol Sci, 299 (1094), 131-3
   DOI 10.1098/rstb.1982.0115, PubMed 6128749
4. Dobloug JH, Førre O, Kvien TK, Egeland T, Degré M (1982)
   Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis
   Ann Rheum Dis, 41 (5), 490-4
   DOI 10.1136/ard.41.5.490, PubMed 6181746
5. Lingaas E, Degré M (1982)
   [Screening for rubella antibodies in newly employed women at the National Hospital]
   Tidsskr Nor Laegeforen, 102 (25), 1272-3
   PubMed 7164071
6. Melby K, Midtvedt T, Degré M (1982)
   Effect of human leukocyte interferon on phagocytic activity of polymorphonuclear leukocytes
   Acta Pathol Microbiol Immunol Scand B, 90 (3), 181-4
   DOI 10.1111/j.1699-0463.1982.tb00102.x, PubMed 6181651
7. Rollag H, Degré M (1982)
   Effect of beta-interferon on in vitro spreading of mouse peritoneal macrophages
   Acta Pathol Microbiol Immunol Scand B, 90 (6), 389-95
   DOI 10.1111/j.1699-0463.1982.tb00136.x, PubMed 7168315
8. Rollag H, Mørland B, Degré M (1982)
   Effect of a homologous beta-interferon preparation on degradation of Escherichia coli and on lysosomal enzyme activities in mouse peritoneal macrophages
   Acta Pathol Microbiol Immunol Scand B, 90 (2), 113-8
   DOI 10.1111/j.1699-0463.1982.tb00091.x, PubMed 6177190
9. Siebke JC, Degré M, Ritland S, Enger SC (1982)
   Prevalence of hepatitis A antibodies in a normal population and some selected groups of patients in Norway
   Am J Epidemiol, 115 (2), 185-91
   DOI 10.1093/oxfordjournals.aje.a113290, PubMed 7058777

Publications 1981

1. Degre M, Glasgow LA (1981)
   Effect of interferon on cyclic adenosine monophosphate levels in cells
   Antiviral Res, 1 (3), 185-92
   DOI 10.1016/0166-3542(81)90007-3, PubMed 6175278
2. Degré M, Rollag H (1981)
   On the possible role of interferon in infections with non-viral agents
   Tex Rep Biol Med, 41, 388-94
   PubMed 6184830
3. Degré M, Sonnenfeld G, Rollag H, Mørland B (1981)
   Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages
   J Interferon Res, 1 (4), 505-12
   DOI 10.1089/jir.1981.1.505, PubMed 6180084
4. Egge K, Djupesland G, Modalsli B, Degré M (1981)
   Severe hearing loss and retinopathy in children: on the possible association with rubella virus infection
   Scand Audiol, 10 (2), 75-9
   DOI 10.3109/01050398109076165, PubMed 7280544
5. Olstad R, Degré M, Seljelid R (1981)
   Production of immune interferon (type II) in cocultures of mouse peritoneal macrophages and syngeneic tumour cells
   Scand J Immunol, 13 (6), 605-8
   DOI 10.1111/j.1365-3083.1981.tb00175.x, PubMed 6171873
6. Rollag H, Degré M (1981)
   Effect of interferon preparations on the uptake of non-opsonized Escherichia coli by mouse peritoneal macrophages
   Acta Pathol Microbiol Scand B, 89 (3), 153-9
   DOI 10.1111/j.1699-0463.1981.tb00169_89b.x, PubMed 6171991

Publications 1980

1. Degré M (1980)
   Antiviral and cell multiplication inhibitory activities of mouse interferon poreparations tested on an interferon sensitive murine sarcoma cell line
   Acta Pathol Microbiol Scand B, 88 (4), 219-23
   DOI 10.1111/j.1699-0463.1980.tb02631.x, PubMed 6158254
2. Degré M (1980)
   Adsorption of interferon to homologous and heterologous cells. Brief report
   Arch Virol, 65 (1), 71-6
   DOI 10.1007/BF01340543, PubMed 6158931
3. Degré M, Rollag H (1980)
   Pathogenesis of Sendasi virus infection in mice. On the possible role of interferon on the development of disease
   Acta Pathol Microbiol Scand B, 88 (3), 177-81
   PubMed 6160724

Publications 1979

1. Degré M, Rollag H (1979)
   Rubella screening by hemolysis-in-gel-test
   Lancet, 2 (8143), 644-5
   PubMed 90314
2. Degré M, Rollag H (1979)
   Screening for rubella antibodies by a single radial haemolysis test
   NIPH Ann, 2 (2), 25-30
   PubMed 398458
3. Degré M, Rollag H (1979)
   Influence of interferon on the in vivo phagocytic activity of reticuloendothelial system cells
   J Reticuloendothel Soc, 25 (5), 489-93
   PubMed 458780
4. Djupesland G, Flottorp G, Degré M, Stien R, Skrede S (1979)
   Cochlear hearing loss and viral infection
   Acta Otolaryngol, 87 (3-4), 247-54
   DOI 10.3109/00016487909126416, PubMed 375666

Publications 1978

1. Degré M (1978)
   Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon
   Proc Soc Exp Biol Med, 157 (2), 253-5
   PubMed 202975
2. Degré M (1978)
   Effect of human leukocyte interferon on the permeability of the cytoplasma membrane of cultured cells
   Acta Pathol Microbiol Scand B, 86B (5), 303-7
   DOI 10.1111/j.1699-0463.1978.tb00048.x, PubMed 716922
3. Degré M, Bukholm G, Lund EE, Djupesland G (1978)
   Attempts to isolate virus from human trigeminal and facial ganglions
   Med Microbiol Immunol, 166 (1-4), 151-6
   DOI 10.1007/BF02121144, PubMed 214678
4. Degré M, Wilhelmsen KW (1978)
   [Interferons. Biological principal and practical application]
   Tidsskr Nor Laegeforen, 98 (24), 1152-4
   PubMed 684722

Publications 1977

1. Degré M, Gláz ET (1977)
   Interferon induction in human cell cultures by small molecular inducers (tilorone and acridines)
   Acta Pathol Microbiol Scand B, 85 (3), 189-94
   DOI 10.1111/j.1699-0463.1977.tb01695.x, PubMed 888701
2. Degré M, Hovig B, Midtvedt T (1977)
   [Can the transport agar method be used for determination of resistance in urinary tract infections?]
   Tidsskr Nor Laegeforen, 97 (5), 248-50
   PubMed 841561
3. Djupesland G, Degré M, Stien R, Skrede S (1977)
   Acute peripheral facial palsy. Part of a cranial polyneuropathy?
   Arch Otolaryngol, 103 (11), 641-4
   DOI 10.1001/archotol.1977.00780280041004, PubMed 200210

Publications 1976

1. Dahl H, Degré M (1976)
   Human interferon and cell growth inhibition. I. Inhibitory effect of human interferon on the growth rate of cultured human cells
   Acta Pathol Microbiol Scand B, 84B (5), 285-92
   DOI 10.1111/j.1699-0463.1976.tb01939.x, PubMed 184682
2. Dahl H, Degré M (1976)
   The effect of ascorbic acid on production of human interferon and the antiviral activity in vitro
   Acta Pathol Microbiol Scand B, 84B (5), 280-4
   DOI 10.1111/j.1699-0463.1976.tb01938.x, PubMed 970135
3. DAHL H, DEGRE M (1976)
   EFFECT OF ASCORBIC-ACID ON PRODUCTION OF HUMAN INTERFERON AND ANTIVIRAL ACTIVITY INVITRO
   ACTA PATH MICRO IM B, 84 (5), 280-284
4. Degré M, Dahl H, Vandvik B (1976)
   Interferon in the serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders
   Acta Neurol Scand, 53 (2), 152-60
   DOI 10.1111/j.1600-0404.1976.tb04333.x, PubMed 1266564
5. Degré M, Hovig T (1976)
   Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells
   Acta Pathol Microbiol Scand B, 84B (6), 347-58
   DOI 10.1111/j.1699-0463.1976.tb01952.x, PubMed 187008
6. Degre M, Vandvik B (1976)
   [Nobel prizes 1976 in physiology and medicine]
   Tidsskr Nor Laegeforen, 92 (33), 1754-5
   PubMed 996844
7. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1976)
   Viral infection as a cause of acute peripheral facial palsy
   Arch Otolaryngol, 102 (7), 403-6
   DOI 10.1001/archotol.1976.00780120051005, PubMed 938319
8. Rollag H, degré M (1976)
   Effect of antibiotics on interferon production in mice
   Acta Pathol Microbiol Scand B, 84B (6), 369-72
   DOI 10.1111/j.1699-0463.1976.tb01954.x, PubMed 998256
9. Vandvik B, Norrby E, Nordal HJ, Degré M (1976)
   Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis
   Scand J Immunol, 5 (8), 979-92
   DOI 10.1111/j.1365-3083.1976.tb03050.x, PubMed 996452

Publications 1975

1. Dahl H, Degre M (1975)
   Separation of antiviral activity of human interferon from cell growth inhibitory effect
   Nature, 257 (5529), 799-800
   DOI 10.1038/257799a0, PubMed 1186865
2. DEGRE M, ELGJO K (1975)
   INFLUENCE OF SYNTHETIC POLYNUCLEOTIDES AND INTERFERON ON INVITRO GROWTH OF CELLS DERIVED FROM A MOUSE SARCOMA
   ACTA PATH MICRO IM A, 1974 248, 61-68
3. Djupesland G, Berdal P, Johannessen TA, Degré M, Stien R, Skrede S (1975)
   The role of viral infection in acute peripheral facial palsy
   Acta Otolaryngol, 79 (3-4), 221-7
   DOI 10.3109/00016487509124677, PubMed 1136761
4. Elgjo K, Degré M (1975)
   Polyinosinic-polycytidylic acid: inhibition of cell proliferation in carcinogen-treated epidermis and in carcinogen-induced skin tumors in mice
   J Natl Cancer Inst, 54 (1), 219-21
   DOI 10.1093/jnci/54.1.219, PubMed 1113302
5. Rollag H, Berdal BP, Bergan T, Degré M, Hovig B, Midtvedt T (1975)
   [Letter: Microstix and N-labstix "Ames"--unsafe for proving bacteriuria]
   Tidsskr Nor Laegeforen, 95 (3), 198
   PubMed 1118846
6. Vandvik B, Degré M (1975)
   Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system
   J Neurol Sci, 24 (2), 201-19
   DOI 10.1016/0022-510x(75)90233-6, PubMed 1113135

Publications 1974

1. Degré M (1974)
   [Virus as a cause of leukemia and blood cell disease in man]
   Tidsskr Nor Laegeforen, 94 (32), 2205-7
   PubMed 4140582
2. Degré M (1974)
   Influence of exogenous interferon on the peripheral white blood cell count in mice
   Int J Cancer, 14 (6), 699-703
   DOI 10.1002/ijc.2910140602, PubMed 4463167
3. Degré M, Dahl H (1974)
   Interferon production and prevention of viral infections in mice by components of a mixed bacterial vaccine
   Acta Pathol Microbiol Scand B Microbiol Immunol, 82 (6), 904-10
   DOI 10.1111/j.1699-0463.1974.tb02390.x, PubMed 4549161
4. DEGRE M, DAHL H (1974)
   INTERFERON-PRODUCTION AND PREVENTION OF VIRAL-INFECTIONS IN MICE BY COMPONENTS OF A MIXED BACTERIAL VACCINE
   ACTA PATH MICRO IM B, B 82 (6), 904-910
5. Degré M, Elgjo K (1974)
   Influence of synthetic polynucleotides and interferon on in vitro growth of cells derived from a mouse sarcoma
   Acta Pathol Microbiol Scand Suppl, Suppl 248, 61-8
   PubMed 4217556

Publications 1973

1. Degré M (1973)
   [Acute effects of cigarette smoke on the respiratory tract]
   Tidsskr Nor Laegeforen, 93 (6), 362-5
   PubMed 4572673
2. Degré M (1973)
   Influence of polyinosinic: polycytidylic acid on the circulating white blood cells in mice
   Proc Soc Exp Biol Med, 142 (4), 1087-91
   PubMed 4694806
3. Degré M, Dahl H (1973)
   Enhanced effect of repeated administration of bacterial vaccine against viral respiratory infection
   Infect Immun, 7 (5), 771-6
   DOI 10.1128/iai.7.5.771-776.1973, PubMed 4357990
4. Degré M, Midtvedt T (1973)
   Effect of standard bacterial vaccine on influenza virus infection and interferon production in germfree mice
   Acta Pathol Microbiol Scand B Microbiol Immunol, 81 (6), 782-6
   DOI 10.1111/j.1699-0463.1973.tb02277.x, PubMed 4521974
5. DEGRE M, MIDTVEDT T (1973)
   EFFECT OF STANDARD BACTERIAL VACCINE ON INFLUENZA-VIRUS INFECTION AND INTERFERON-PRODUCTION IN GERMFREE MICE
   ACTA PATH MICRO IM B, B 81 (6), 782-786
6. Vandvik B, Froland SS, Hoyeraal HM, Stien R, Degré M (1973)
   Immunological features in a case of subacute sclerosing panencephalitis treated with transfer factor
   Scand J Immunol, 2 (4), 367-74
   DOI 10.1111/j.1365-3083.1973.tb02045.x, PubMed 4797728

Publications 1972

1. Dahl H, Degré M (1972)
   A micro assay for mouse and human interferon
   Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (6), 863-70
   DOI 10.1111/j.0365-5563.1973.tb00012.x, PubMed 4345661
2. Dahl H, Degré M (1972)
   Preventive effect of a nonviral interferon inducer, a bacterial vaccine, on experimental influenza in mice
   Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 467-74
   DOI 10.1111/j.1699-0463.1972.tb00062.x, PubMed 4505773
3. DAHL H, DEGRE M (1972)
   MICRO ASSAY FOR MOUSE AND HUMAN INTERFERON
   ACTA PATH MICRO IM B, B 80 (6), 863-870
4. Degré M (1972)
   Effect of a standard bacterial vaccine on infection with an obligate intracellular parasite (Toxoplasma gondii) in mice
   Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (3), 478-80
   DOI 10.1111/j.1699-0463.1972.tb00064.x, PubMed 4505774
5. Degré M (1972)
   [Possible interaction between viral and bacterial agents in respiratory tract infections]
   Tidsskr Nor Laegeforen, 92 (8), 556-8
   PubMed 5021893
6. Degre M (1972)
   [Slow virus infections]
   Tidsskr Nor Laegeforen, 92 (11), 783-5
   PubMed 5063782
7. Degré M, Vandvik B, Hovig T (1972)
   Subacute sclerosing panencephalitis: isolation and ultrastructural characterization of a measles-like virus from brain obtained at autopsy
   Acta Pathol Microbiol Scand B Microbiol Immunol, 80 (5), 713-28
   DOI 10.1111/j.1699-0463.1972.tb00199.x, PubMed 4629361

Publications 1971

1. Degré M (1971)
   Synergistic effect in viral-bacterial infection. 4. The leukocyte response to parainfluenza virus infection in the respiratory tract of mice, and the influence of antibiotics on the development of infection
   Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 88-94
   PubMed 4324936
2. Degré M (1971)
   Synergistic effect in viral-bacterial infection. 5. Functional studies on the role of the ciliary activity in the mouse trachea
   Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 137-41
   PubMed 4325914
3. Degre M, Dahl H (1971)
   Production of an interferon-like agent following inoculation with bacterial vaccine
   Proc Soc Exp Biol Med, 137 (1), 233-6
   DOI 10.3181/00379727-137-35551, PubMed 4325773
4. Degré M, Elgjo K (1971)
   Methylcholanthrene-induced skin carcinogenesis modified by treatment with polyinosinic:polycytidylic acid (poly I:C)
   Acta Pathol Microbiol Scand A, 79 (6), 687-8
   PubMed 5123526
5. Degré M, Midtvedt T (1971)
   Respiratory infection with parainfluenza 1, Sendai virus in gnotobiotic and conventional mice
   Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (1), 123-4
   DOI 10.1111/j.1699-0463.1971.tb00042.x, PubMed 4324935
6. Degré M, Solberg LA (1971)
   Synergistic effect in viral-bacterial infection. 3. Histopathological changes in the trachea of mice following viral and bacterial infection
   Acta Pathol Microbiol Scand B Microbiol Immunol, 79 (2), 129-36
   PubMed 4325913

Publications 1970

1. Degré M (1970)
   Synergistic effect in viral-bacterial infection. 2. Influence of viral infection on the phagocytic ability of alveolar macrophages
   Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (1), 41-50
   PubMed 4316170
2. Degré M (1970)
   [Quantitative and semiquantitative methods for the diagnosis of bacteriuria]
   Tidsskr Nor Laegeforen, 90 (1), 27-30
   PubMed 5426183
3. Skjorten F, Kierulf PB, Degré M (1970)
   Formation of hyaline microthrombi in the mouse. Evidence for dependence on the fibrinolytic system
   Acta Pathol Microbiol Scand A, 78 (3), 351-61
   PubMed 5507260

Publications 1969

1. Degré M (1969)
   Phagocytic and bactericidal activities of peritoneal and alveolar macrophages from mice
   J Med Microbiol, 2 (3), 353-7
   DOI 10.1099/00222615-2-3-353, PubMed 5314333

Publications 1968

1. Degré M (1968)
   [Etiological disgnosis of purulent meningitis]
   Tidsskr Nor Laegeforen, 88 (12), 1091-4
   PubMed 4387023
2. Degré M, Glasgow LA (1968)
   Synergistic effect in viral-bacterial infection. I. Combined infection of the respiratory tract in mice with parainfluenza virus and Hemophilus influenza
   J Infect Dis, 118 (5), 449-62
   DOI 10.1093/infdis/118.5.449, PubMed 4302684

Publications 1967

1. Degré M (1967)
   Reproducibility of staphylococcal bacteriophage types by use of different concentrations of bacteriophage
   Appl Microbiol, 15 (4), 907-11
   DOI 10.1128/am.15.4.907-911.1967, PubMed 4227800

Publications 1966

1. Degré M (1966)
   Bacteriophage typing of Staphylococcus aureus using a single concentration of phage (100 x RTD)
   Acta Pathol Microbiol Scand, 66 (1), 105-12
   DOI 10.1111/apm.1966.66.1.105, PubMed 4224085
2. Degré M (1966)
   Simple quantitative methods in the bacteriological diagnosis of urinary tract infection
   J Oslo City Hosp, 16 (8), 184-96
   PubMed 5329982

Publications 1965

1. Degrè M, Ulstrup JC (1965)
   [Bacteriological studies on otitis media. 1-year case material]
   Tidsskr Nor Laegeforen, 85 (12), 994-7
   PubMed 5864803
2. Daae L, Degré M (1965)
   [Bacteriological studies of urine. A comparison between washed down specimens and catheterized specimens from bedridden women]
   Tidsskr Nor Laegeforen, 85 (12), 1003-5
   PubMed 5865811

Publications 1964

1. DEGRE M (1964)
   [DISINFECTION OF THE DUMMY FIGURES USED IN TRAINING FOR MOUTH-TO-MOUTH RESPIRATION METHODS]
   Tidsskr Nor Laegeforen, 84, 1112-4
   PubMed 14230470

Publications 1962

1. DEGRE M (1962)
   [Anaphylactic reaction to carisoprodol]
   Tidsskr Nor Laegeforen, 82, 1589
   PubMed 14026463

Publications 1957

1. TIGYI A, LISSAK K, DEGRE M, PETER K (1957)
   [Role of neurohormonal factors in pathological changes in lungs]
   Magy Tud, 8 (1-2), 86-9
   PubMed 13450585